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Steroid production requires an enormous energy requirement from the cell.  The 
pathway responsible for the production and metabolism of cholesterol in mammalian 
systems is complex and is the focus of intensive study.  Steroids in multicellular 
organisms are thought of classically to have one primary cellular effect: alteration of 
nuclear transcription characterized by a latency period between signal and effect.  
Classical steroid binding proteins are members of the nuclear receptor superfamily.  They 
bind to steroids in either the cytosol or nucleus, dimerize, then migrate to the nuclear 
genome and act as transcription factors.  Recent research suggests some steroids may be 
involved in a rapid onset of cellular effects not caused by an alteration in gene 
expression.  Membrane binding sites for progesterone have been described and, at least in 
part, characterized in tissues or cells exhibiting non-genomic progesterone actions, thus 
pointing to a link between putative membrane receptors and rapid steroid effects. 
 MAPRs (Membrane Associated Progesterone Receptors) have been implicated in 
mediating a number of rapid cellular effects not involving changes in gene expression.  
MAPRs have no significant sequence similarity to classical steroid receptors.  The 
MAPR homologues as a group have been suggested to play widely varying roles from 
axon guidance, to steroid hydroxylation and steroid metabolism, to influencing 
reproductive behavior.  Their specific role has not yet been clearly demonstrated in any 
organism.   
 Dap1p is the yeast homologue of MAPR.  Although yeast do not produce steroid 
compounds they do produce sterols, which are precursor to steroids.     
 xii
Statement of the Problem 
 
 Deletion of DAP1 in haploid strains produced an altered sterol profile.  The goal 
of this study was to further characterize this protein genetically and biochemically in 




 The first objective was to characterize the growth rate of the dap1∆ mutant strain 
and the ypr118w∆ mutant strain in various media and determine how these rates 
compared to the growth rate of the control strain.  Also, the strains were grown in 
competition experiments against the control in YPD medium, SLAD medium, and SPHD 
medium.  The data demonstrated there is no significant difference in growth rates in YPD 
medium.  In SLAD medium (nitrogen starvation) the dap1∆ mutant strain outcompeted 
the control strain, and the control strain outcompeted the ypr118w∆ mutant strain.  In 
SPHD medium (nitrogen limiting), there was no significant difference in the growth rates 
between the dap1∆ mutant strain and the control stain, but the  ypr118w∆ mutant strain 
exhibited a slower growth rate as compared to the control strain. 
The second objective was to determine and characterize the localization pattern(s) 
of Dap1p and Ypr118wp.  The Dap1p-GFP fusion protein localized to lipid particles.  
The Dap1p-GFP fusion protein also localized peri-nuclearly, suggesting it also localizes 
to the ER.  The Ypr118w-RFP2 fusion protein localized to lipid particles and co-localized 
with Dap1p-GFP when expressed in the same cell.   
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 Upon addition of MMS to cells transformed with DAP1-GFP, the Dap1p-GFP 
fusion protein still localized to lipid particles, but the protein exhibited a higher 
percentage to localize peri-nuclearly. 
 The third objective was to determine the localization pattern exhibited by 
Hpr6.6p-GFP under normal growth conditions and also in the presence of MMS in HeLa 
cells.  Hpr6.6p-GFP localized to the ER in HeLa cells under normal conditions and upon 
addition of MMS. 
 The fourth objective was to show if the dap1∆ mutant strain was sensitive to 
MMS as compared to the control strain.  The dap1∆ mutant strain exhibited a higher 
sensitivity to YPD plates supplemented with MMS as compared to control, the ypr118w∆ 
mutant strain did not exhibit any increased sensitivity as compared to the control stain, 
and the dap1∆/ypr118w∆ double mutant strain exhibited sensitivity compable to the 
dap1∆ mutant strain.  
 The fifth objective was to determine if the dap1∆ mutant strain, the ypr118w∆ 
mutant strains, and the dap1∆/ypr118w∆ double mutant strain exhibited elevated petite 
formation as compared to the control strain.  The dap1∆ mutant strain and the 
dap1∆/ypr118w∆ double mutant strain exhibited increased petite formation, the 
ypr118w∆ mutant strains did not exhibit increased petite formation as compared to the 
control strain. 
 The sixth objective was to determine and characterize the free sterol profiles and 
the steryl ester profiles of the control strain and the dap1∆ mutant strain at 1 day old 
culture and 2 day old cultures.  The dap1∆ mutant strain exhibited significant altered 
sterol profile in both the free sterol fraction and the steryl ester fraction as compared to 
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the control strain.  Addition of Dap1p under the control of the constitutive promoter, 
Gpd, to the dap1∆ mutant strain increased total sterol content to levels almost consistent 
with levels in the control strain, but with significant and, perhaps, elucidating differences 
between the strains.  Upon addition of Hpr6.6p under the control of the copper promoter, 
CUP1, both the control strain and the dap1∆ mutant strain exhibited increased ergosterol 
production in both the free sterol fraction and the steryl ester fraction when Hpr6.6p was 
expressed in these strains.  These data are consistent with the hypothesis that the primary 
function of Dap1p is in cellular sterol metabolism.  Dap1p localized to lipid particles and 
to the ER, known sites of sterol biosynthesis.  Deletion of DAP1 resulted in a reduction of 
ergosterol and accumulation of alternative late-stage intermediates in the ergosterol 
biosynthesis.  Overexpression of either Dap1p or Hpr6.6, the human homolog, in the 
dap1∆ mutant strain resulted in elimination of the alternative intermediates and 







Membrane Associated Progesterone Receptors (MAPRs) 
 Enzymes involved in cellular steroid perception can be broken down into two 
major categories; those enzymes that bind steroids/steroid precursors that are involved in 
the production of specific steroids and those enzymes that bind steroids which are 
involved in mediating a response to the steroids produced.  Cholesterol serves as bulk 
membrane support in mammalian cells.  But, cholesterol is also the precursor to steroid 
compounds in mammals.  Cholesterol production, utilization, and enzymatic 
transformation to steroid compounds in mammalian systems have been intensively 
studied, yet many questions still remain.   
  Two different routes of cellular effects are mediated by steroids; genomic and 
non-genomic.  The classical pathway of action of steroid hormones and related 
compounds is mediated by the binding of the steroid hormone to specific nuclear 
receptors.  These receptors then bind to nuclear DNA, alters the transcription of genes 
and, thus, affect the eventual alteration of a variety of cellular functions [3,4].  This mode 
of action is characterized by a latency period between steroid signal reception and 
cellular effects.  The nuclear steroid hormone receptors elicit a response characterized by 
a substantial delay of a few hours to days [4].  To date, the most rapid steroid hormone 
effect on transcription is for glucocorticoids effect on mouse mammary tumor virus long 
terminal repeat in mouse L(tk aprt) cells, in which transcription was detectable within 7.5 
minutes after glucocorticoid application [5].  Classical receptors include members of the 
steroid/thyroid hormone receptor superfamily [9].  These are characterized by a helical 
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sandwich structure which binds the steroid ligand [10].  These receptors can be located in 
the nucleus or cytosol.  Upon binding of ligand, steroid receptors dimerize and migrate to 
the nuclear genome, whereupon they act as transcription factors [9].  
 Recently, there has been great interest focused on the characterization of non-
genomic responses to steroid/hormone compounds.  Recent observations support the 
existence of a non-genomic response to steroid compounds, characterized by rapid onset 
of cellular response.  These response times can be anywhere from a few seconds to a few 
minutes [17].  Progesterone was the first of these examples; it was demonstrated to 
produce a rapid anesthetic effect in the central nervous system [7].  This has recently 
been determined to be mediated by an effect progesterone has on GABAA receptors [15].  
Rapid effects have now been described for most classes of steroids [8].  Each steroid 
seems to be able to produce many different rapid responses.  In the individual case of 
progesterone, such rapid effects include: the previous described anesthetic effect in the 
CNS, calcium influx and chloride efflux in sperm during the acrosome reaction [11,12], 
depolarization of rat hepatocytes by decreasing the cell-membrane potassium 
conductance [13], calcium influx in Xenopus oocytes [14], and, more recently, inhibition 
of the action of oxytocin through direct binding to the uterine oxytocin receptor [16]. 
 The time dependence of different actions of steroid presents a useful way of 
categorizing different types of steroid action.  Very rapid effects like ion fluxes, 
triggering of action potentials, or discharge of secretory vesicles happen within a 
timeframe of seconds to minutes.  Somewhat slower responses might arise from the 
activation of enzymes or pumps, whose product would be generated immediately, but 
would only build up to detectable and functional levels over time.  Long-term responses, 
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such as those that are associated with gene expression mediated by steroid receptors 
acting as transcription factors, require events that eventually alter functional or structural 
proteins or their levels.  Finally, very long-term events may develop over the 
maturational time course of the organism to produce permanent developmental tissue 
remodeling.  A number of different novel steroid receptors, or even splice variants, are 
likely to be involved in mediating these different non-genomic actions of steroid.   
 A putative membrane-associated steroid receptor (MAPR) with high affinity for 
progesterone was first identified in porcine liver membranes [25].  This paper and later 
papers by the same group suggested that MAPRs elicit a non-genomic response to 
progesterone or derivatives, without providing concrete evidence of actual progesterone 
binding by MAPRs.  This porcine protein, named mPR, was later cloned and sequenced 
from porcine vascular smooth-muscle cells [18].  CHO cells transfected with the coding 
sequence for the porcine mPR demonstrated an increase in microsomal progesterone 
binding, in vitro [24].  Antibodies raised against recombinant porcine mPR inhibited the 
progesterone-initiated Ca
2+
 flux in human sperm [24].   In addition, rabbit antibodies 
raised against a synthetic peptide, corresponding to the first 15 N-terminal amino acid 
sequence of the porcine mPR, inhibited the progesterone-initiated acrosome reaction of 
human sperm, and revealed localization to the plasma membrane [26].  Although these 
events are very suggestive, no direct evidence for progesterone binding in vivo or in vitro 
to mPR has yet been presented.  Sub-cellular fractionation studies in porcine hepatocytes 
and immunofluorescence in HEK cells transfected with porcine mPR identify porcine 
mPR to be localized on the ER and Golgi apparatus [27].   
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Subsequently, homologous MAPR sequences in human [19], rat [20], mouse [21], 
and yeast [22] were cloned.  Homologues sequences are also found, but not limited to, 
and studied in mouse (two sequences), cow, C. elegans, Arabidopsis thaliana (five 
sequences), and Oryza sativa (two sequences) [23].  These sequences were found to bear 
no significant sequence similarity to the classical genomic intracellular receptors.  But, 
these sequences of the MAPR family, along with sequences of some fungal chitin 
synthases and HERC2 proteins, have been identified as being distantly related to the 
cytochrome b5 family of proteins, which bind heme [23].  MAPRs do not appear to bind 
heme or to be involved in redox reactions, since they all lack the pair of heme-
coordinating histidine residues [23].  This suggests the heme binding site of cytochrome 
b5 may have served as a template for the evolution of novel ligand-binding pockets, such 
as the steroid binding site in MAPRs. 
 Two MAPRs are found in humans; Hpr6.6 and Dg6.  Hpr6.6 is the human MAPR 
homologue of the porcine mPR.  Hpr6.6 mRNA is expressed predominantly in liver and 
kidney, whereas Dg6 mRNA is preferentially expressed in placenta [19]. Hpr6.6 has 
recently been suggested to mediate cell death from oxidative damage via a mechanism 
that is not typical of the apoptotic pathway [103]. The rat MAPR homologue, 25-Dx, is 
expressed in the ventromedial hypothalamus of female rats, a region of the brain that 
plays a role in reproductive behavior mediated by steroid hormones [28].  25-Dx 
localized to the plasma membrane in those neurons.  The data indicate 25-Dx was down-
regulated by progesterone and up-regulated by estrogen in female rat brain.  Recently, 
25-Dx has been localized to neuronal Purkinje cells and the external granule cell layer 
[110].  Purkinje cells synthesis progesterone de novo from cholesterol only during 
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neonatal life.  The authors suggest that progesterone promotes dendritic growth, 
spinogenesis, and synoptogenesis via 25-Dx as well as the nuclear progesterone receptor.  
This same rat MAPR was isolated, in a different experiment setup and by a different 
group, as a protein specific to the inner zones of the rat adrenal cortex, called inner zone 
antigen (IZAgI) [30].  IZAg was localized to both the microsomal and mitochondrial 
fractions.  IZag was proposed to have an action on steroid hydroxylation, since 
monoclonal antibodies raised against IZAg cause a dose dependent decrease in 
hydroxylation of progesterone in the microsomal fraction and a decrease in hydroxylation 
of deoxycorticosterone in the mitochondrial fraction.  Recently, IZag has been proposed 
to play a role in adrenocorticol steroidogenesis [106].  When COS-7 cells were 
transformed with plasmids for appropriate steroidogenic enzymes in the presence or 
absence of an IZAg expression plasmid and tested for their steroidogenic activities, 21-
hydroxylation of progesterone was found to be specifically activated by IZAg 
overexpression, suggesting the involvement of IZAg in progesterone metabolism.  This 
was the first instance linking the involvement of MAPRs to steroid metabolism.  The 
same rat MAPR was isolated yet again as a ventral midline antigen, VEMA, expressed in 
the central nervous system of rat embryos [29].  The floor plate is composed of a small 
group of columnar ependymal cells that reside at the ventral midline of the developing 
vertebrate CNS.  These cells play key roles in pattern formation and axon guidance.  In 
situ hybridization analysis demonstrated VEMA mRNA being predominantly expressed 
at the ventral midline.  Thus, the researchers suggest a role for VEMA in regulating axon 
guidance.  The researchers proposed that several lines of evidence suggested VEMA does 
not bind progesterone and that progesterone is not present within the developing rat 
 6 
spinal cord [29].  Unfortunately, the researchers did not present what kinds of studies 
were examined and no data was presented as proof of this claim.   
 Dap1p is the yeast MAPR homologue.  Yeast are unicellular organisms, which 
obviously have no liver, no neuronal cells, or even a CNS.  Yeast do not produce steroid 
compounds, although they do produce sterols, which are precursors to steroid compounds 
in higher organisms.  Although strains used in the study were haploid, deletion of DAP1 
has been demonstrated to lead to sensitivity to MMS, elongated telomeres by ~100bp, 
defects in mitochondrial biogenesis, and partial arrest of sterol synthesis [66].  
Specifically, the dap1∆ mutant strain exhibited decreased levels of ergosterol and 
zymosterol and increased levels of lanosterol and squalene as compared to control strain.  
It is uncertain as to whether Dap1p is intimately involved in the MMS induced DNA 
damage response, telomere maintenance, and mitochondrial biogenesis or if it is a by-
product created by the altered sterol profile, or even if they are a result of an unknown 
secondary mutation, since haploid strains were used.   
 Previous characterization of diploid homozygous mutant strain has shown a 
differential sensitivity to alcohol, an altered sterol profile, and a strong yeast two-hybrid 
interaction with Ypr118wp [22].  Ypr118wp was recently shown to be a 
methylthioribose-1-phosphate isomerase, an enzyme of the methionine salvage pathway 
[86].  High-throughput screens have found that Dap1p interacts genetically with Erg11, 
lanosterol 14α-demethylase [112], co-precipitates with Pma1p (H
+
-ATPase) and Guf1 (a 
GTPase located in mitochondria) [111], and interacts in a yeast two-hybrid screen with 
Tfb1 (a subunit of TFIIH and nucleotide excision repair factor 3 complexes) [113].   
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 Various microarray experiments have shown that DAP1 mRNA accumulates in 
response to nitrogen depletion and as cells enter stationary phase [114].  Dap1p mRNA in 
haploid a cells peaks 60 minutes after alpha-factor application.  In diploid cells 
undergoing meiosis and sporulation, Dap1 mRNA shows a biphasic induction, at 0.5 h 
and at 7 h of sporulation.  The Schizosaccharomyces pombe homologue SPAC25B8.01 
also shows an interesting pattern of expression during meiosis; increased expression 
going through meiosis I and II and marked decreased expression afterwards.   
 These prior observations do not point to an obvious primary function fro Dap1p 
or the mammalian MAPR homologues.  Rather, they indicate pleitropic effects in 
different cell compartments, from nuclei to the ER, mitochondria and the plasma 
membrane, from DNA damage responses to sterol metabolism to a receptor for steroids.  
Nevertheless, combining the facts that deletion of DAP1 produces an altered sterol profile 
with the observation that mammalian MAPRs might be involved in steroid metabolism 
one can propose that Dap1p plays a direct role in sterol metabolism in the yeast cell.  A 
role in sterol metabolism would be consistent with the genetic interaction of Dap1p with 
Erg11p.  Moreover, sterol biosynthesis involves a number of membrane systems, from 
ER to lipid particles to mitochondria and the plasma membrane, and sterols affect a 
variety of cellular functions, including endocytosis, amino acid transport, and the cell 
division cycle.  Therefore, a mutation in a gene in sterol metabolism may will have 






 Sterols are thought to serve a number of functions in yeast.  The most important 
of these include bulk membrane support – relating to membrane fluidity and permeability 
[48], the cell cycle ‘sparking function’ [48], involvement in endocytosis and exocytosis 
[49], and ‘lipid raft’ formation [50,51].   Recently, preliminary studies have described 
some physiological properties and effects of sterols on aerobic metabolism [74,75], 
completion of the cell cycle [76], sterol uptake [77], and sterol transport in mitochondria 
[65]. Sterols are essential components of the eukaryotic plasma membrane.  Sterols are 
highly enriched in the plasma membrane [37,38,39]; other organelles contain sterols at 
lower, although still significant quantities [40].  The sterol content of the plasma 
membrane changes depending upon the nature of the external conditions: heat, pH, ions, 
EtOH, etc.  The mechanism of their transport from internal membranes, where they are 
synthesized, to the periphery of the cell is still obscure [2].  Ergosterol is the major sterol 
present in the cell, but there are a number of other sterols present.  The structural 
differences are thought to serve not only a differential function of membrane rigidity and 
permeability, but might also be important for the electrical potential across each 
membrane. 
Yeast sterols are known to be produced from isopentyl diphosphate, the central 
intermediate in sterol/isoprenoid biosynthesis. There are at least two known biochemical 
pathways that produce isopentyl diphosphate [41].  The major pathway and, also, the best 
understood, is production from acetyl-CoA.  But isopentyl diphosphate can also be 
produced from D-glyceraldehyde-3-phosphate + pyruvate.  This pathway is not 
understood very well, all the enzymes involved and steps are not known, and seems to be 
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used little.  Ultimately, three isoprene units are joined to form farnesyl diphosphate.  
Squalene synthase catalyzes two consecutive reactions in sterol biosynthesis; the 
condensation of two molecules of farnesyl diphosphate to form the cyclopropylcarbinyl 
intermediate presqualene diphosphate, and the subsequent rearrangement and reduction 
of prequalene diphosphate to form squalene [31].  This reaction is the first pathway-
specific step in yeast sterol metabolism.  Squalene is then epoxidized by squalene 
epoxidase, then circulized by lanosterol synthase to produce lanosterol, the first sterol in 
the ergosterol biosynthetic pathway.  Lanosterol then undergoes thirteen enzymatic 
reactions by ten different enzymes to finally produce ergosterol; this is summarized in 
Tables 1a and 1b.   
These are not all the sterols found in the yeast Saccharomyces cerevisiae.  Yeast 
can also produce trace amounts of sterol byproducts during double-bond migration in the 
conversion of lanosterol to ergosterol [42].  More significantly, yeast can produce traces 
of aberrant sterols by minor alternate pathways [104].  Also, evidence suggests that minor 
mutations in the enzymes involved in the production of ergosterol can create sterols not 
normally observed in yeast.  This can be achieved by either binding to a different sterol 
ligand and performing the correct enzymatic reaction, or by binding to the correct ligand, 
but catalyzing an aberrant enzymatic reaction [105]. Levels of these abnormal 
metabolites and related biosynthetic intermediates can increase dramatically when normal 
metabolism is disrupted by genetic defects [43,44,45] or sterol inhibitors [46,47]. 
Classically, the site of sterol synthesis is considered to be in the microsomal 
fraction [56].  Sites of synthesis have been determined to include both the surface of the 
ER and, recently, the participation of lipid particles, since the localization of the enzymes 
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involved in the ergosterol biosynthetic pathway are localized to both the ER [52,53] and 
lipid particles [36,54,55].  All types of eukaryotic cells, such as plants [32,33], mammals, 
[34], and yeast [35], contain intracellular lipid particles.  These particles consist of a 
highly hydrophobic core formed from neutral lipid particles (triacylglycerols and steryl 
esters) surrounded by a phopholipid monolayer in which only a few proteins are 
embedded [36].   
Ergosterol biogenesis occurs primarily during exponential growth.  When cells 
start to reach stationary phase and during sporulation, the excess sterols are esterified to 
produce and accumulate steryl esters [62].  Sterols are esterified with long-chain fatty 
acids in the ER [63], and steryl esters so formed are stored in lipid particles together with 
triacylglycerols [1,2,57].  Depending on the growth stage, steryl esters are metabolically 
interconvertible with free sterols [54,58].  The enzyme catalyzing the hydrolytic cleavage 
of steryl esters, steryl ester hydrolase, was detected at highest specific activity in the 
plasma membrane [2].  There are two known steryl ester hydrolases present in 
Saccharomyces cerevisiae, Are1p and Are2p [63].  This spatial separation of enzymes 
involved in the synthesis of sterols and steryl esters, and in the hydrolytic cleavage of the 
latter components necessitates several steps of intracellular sterol transport.  This holds 
true for the biosynthesis and metabolism of both the free sterols and the steryl esters.  
Mechanisms proposed, for sterol translocation, are monomer transport with or without 
the aid of sterol carrier proteins, or vesicle flow with or without an involvement of the 
protein secretory machinery [59,60].  Nothing conclusive is yet known about the cellular 
mechanism(s) leading to the deposition of steryl esters to the hydrophobic lipid particles, 
or about their export from lipid particles to the plasma membrane during the mobilization 
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and utilization of this sterol source.   Results seem to support the view that ongoing 
membrane proliferation may be a driving force [61].   
 Normally, ergosterol accounts for most of the sterol fraction in the cell, but its 
relative quantity can vary depending upon the metabolic state of the cell.  This relative 
quantity can change widely particularly if there are mutations in enzymes involved in the 
ergosterol biosynthetic pathway.  Erg4p is the last enzyme in the ergosterol biosynthetic 
pathway; it catalyzes the conversion of ergosta-5,7,22,24(28)-tetraen-3β-ol into 
ergosterol.  Erg4p is localized to the ER [55], therefore ergosterol must be supplied 
somehow from its location of biosynthesis to it destination membrane.  The protein(s) or 
mechanism(s) responsible for this is unknown. 
 Lanosterol is the first sterol produced in the ergosterol biosynthetic pathway.  It is 
produced by the addition of oxygen to squalene in which squalene epoxide is an 
intermediate between squalene and lanosterol.  Squalene is converted into squalene 
epoxide by Erg1p.  Squalene epoxide is converted into lanosterol by Erg7p.  Both Erg1p 
and Erg7p localize to both lipid particles and on the ER.  Erg1p is mainly localized to the 
ER, ~62%, with lesser quantities in lipid particles, ~38% [70], whereas Ergp7p is mainly 
localized to lipid particles with only minor quantities being present in the ER [71].  
Interestingly, Erg1p is not active in lipid particles, but partial activity can be activated 
when lipid particles are mixed with microsomes devoid of Erg1p, indicating that there is 
a factor in the ER that is necessary for squalene epoxidase activity [73].  Erg1p 
transcriptional expression is regulated by ergosterol levels in the cell [72].  Since, 
lanosterol in the first sterol in the pathway, it is a pivotal point for the variations so 
commonly observed.  Thus lanosterol is an excellent indicator sterol that may change 
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significantly depending upon the physiological state of the cell.  A C-14 methyl-group is 
removed from lanosterol by Erg11p, to produce 4,4-dimethylcholesta-8,14,24(28)-trien-
3β-ol.  Erg11p has been demonstrated to be located on the ER [78].  Erg11p has been 
identified by large scale interaction studies to genetically interact with Dap1p [79]. 
Erg6p catalyzes the conversion of zymosterol into fecosterol.  Erg6p has been 
demonstrated to be located as a surface protein in lipid particles [36].  Erg6p is the first 
enzymes in the ergosterol biosynthetic pathway to be non-essential for viability in 
Saccharomyces cerevisiae cells.  Erg3p catalyzes the conversion of ergosta-5,7,22-trien-
3β-ol into ergosta-5,7,22,24(28)- tetraen-3β-ol.  It has been demonstrated that 
mitochondria function as important physiological partners with Erg3p in accumulation of 
toxic sterol intermediate [80], supplying a connection between mitochondria and 
ergosterol production.  Recent data suggests that Erg27p interacts with Erg7p, facilitating 
Erg7p interaction with lipid particles and also preventing digestion of Erg7p in the ER 
and lipid particles [81], providing evidence that this enzyme performs more than one role 
in the cell.  Erg28p has been suggested to tether Erg26p and Erg27p to the ER or to 
facilitate an interaction between the two proteins [82], suggesting protein complexes form 
to facilitate the enzymes in the ergosterol biosynthetic pathway.  Erg25p is a sterol C-4 
methyloxidase, performing multiple enzymatic steps in the ergosterol biosynthetic 
pathway [73], but it is also required to grow on iron-limiting media [83].  It is localized to 
both the ER and in minor quantities on the plasma membrane, and data suggests that this 
protein is not regulated by iron, but by an end product of the ergosterol biosynthetic 
pathway [83].  It has been well established that ergosterol regulates its own biosynthesis 
through a feedback mechanism [84].   
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A major focus of this dissertation is to analyze the sterol profiles in the dap1∆ mutant 
strain for alterations that provide insight into the role of Dap1p in sterol metabolism.  
Both free sterols and esterified sterols will be analyzed.  Because sterol metabolism 










Media and Growth conditions   
 
Yeast were grown in YPD [1% Bacto-yeast extract, 2% Bacto-peptone, 2% 
dextrose (or 3% glycerol for YPG), pH 5.8 and 2% agar for plates] (complete) or minimal 
SD medium (0.17% yeast nitrogen base without ammonium sulfate or amino acids, 0.5% 
ammonium sulfate, 1x amino acids, 2% dextrose, pH 5.8 and 2% agar for plates) unless 
otherwise noted. 
 
Low Nitrogen Media 
 
 SPD [1g proline, 20g dextrose, 6.7g YNB without amino acids or ammonium 
sulfate, 1X uracil, histidine, and leucine] + dH2O to make one liter. 
 SLAD [6.61mg (NH4)2SO4, 20g dextrose, 6.7g YNB without amino acids and 




 Colonies were streaked from glycerol stocks onto fresh selective SD media and 
incubated at 30ºC for 24 hours.  Colonies were removed by scrapping and used to 
inoculate 10mL YPD at 5x10
5
 cells/mL.  Cultures were grown at 30ºC, 220 rpm for 8 
hours.  Cell concentration was determined by direct cell count on a hemacytometer and 
used to inoculate a fresh 10mL YPD liquid culture in 50 mL tube with the cap on tight at 
a concentration of 5x10
3
 cells/mL/strain for a total of 1x10
4
 cells/mL.  Cultures were 
grown at 30ºC with shaking at 220 rpm.  At specified time points, aliquots were taken 




 Colonies were streaked from glycerol stocks onto fresh selective SD media and 
incubated at 30ºC for 24 hours.  Colonies were removed by scrapping and used to 
inoculate 10mL YPD at 5x10
5
 cells/mL.  Cultures were grown at 30ºC, 220 rpm for 8 
hours.  Cell concentration was determined by direct cell count on a hemacytometer and 
used to inoculate a fresh 10mL liquid culture in 50 mL tube with the cap on tight at a 
concentration of 5x10
3
 cells/mL/strain for a total of 1x10
4
 cells/mL.  Cultures were 
grown at 30ºC with shaking at 220 rpm.  At specified time points, aliquots were taken 
and spread onto YPD plates and allowed to incubate at 30ºC overnight.  Colonies were 
counted, replica plated onto either SD+geneticin for dap1∆ mutant strain selectivity or 
SD-URA for ypr118w∆ mutant strain selectivity, and allowed to incubate at 30ºC 
overnight.  Every seven days, 1x10
5
 cells (total), determined by direct cell count on a 




 Transformation of yeast was achieved by the LiAc/PEG protocol.  Briefly, one 
colony was used to inoculate 5mL YPD liquid media, cells were allowed to grow 
overnight at 30ºC with shaking at 220rpm.  The next day, 5mL fresh YPD was added to 
the solution and incubated 30ºC with shaking at 220rpm for 2-4 hours, to an OD600 = 1.0 
to 5.0.  Cells were spun down for 10min at 4,500 x g and the supernatant discarded.  
Next, 7mL of 0.1 M LiAc-TE solution was added and the cells incubated at 30ºC with 
shaking at 220rpm for 60 minutes.  Cells were again centrifuged, and then resuspended in 
1mL 0.1 M LiAc-TE solution.  In a microfuge tube, 100µL of cells, 20µg of carrier 
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DNA, and 10µg of transforming DNA were mixed and incubated for 30 minutes at 30ºC.  
Next, 700µL of LiAc-PEG-TE solution was added and incubated for 30 minutes at 30ºC.  
The cells were then heat shocked at 42ºC for 10minutes, left at room temperature for 60 




All experiments in this study were carried out using homozygous diploid yeast 
strains of Saccharomyces cerevisiae.  All yeast strains used in this study are described in 
Table 2.  Strain JCY2 is a strain from the Stanford Yeast Deletion Project (Research 
Genetics), now available from Invitrogen (San Diego, California), in which the native 
DAP1 sequence is disrupted by insertion of  the KanMX6 (an aminoglycoside 
phosphotransferase), selectable on media containing geneticin.  Strain PGY11, created by 
Dr. Phillip Gray (Georgia Institute of Technology), is a knockout strain, in which the 
native YPR118W sequence was disrupted by insertion of a URA3 gene, selectable on 
media lacking uracil.  Strain PGY21, created by Dr. Phillip Gray, is a strain created from 
mating haploids from both the JCY2 strain and the PGY11 strain, in which both genes 


















 A sterile velvet patch was secured onto a replica block with the plastic ring.  The 
master plate was marked for orientation.  The master plate was then placed onto the 
velvet, colonies facing the velvet, and pressed lightly.  A fresh plate, oriented like the 




Colonies were streaked from glycerol stocks onto fresh selective SD media and 
incubated at 30ºC for 24 hours.  Colonies were scraped and used to inoculate 10mL YPD 
at 5x10
5
 cells/mL.  Cultures were grown at 30ºC, 220 rpm for 8 hours.  Cell concentration 
was determined by direct cell count on a hemacytometer and used to inoculate a fresh 
YPD plate at about 150 cells per plate.  Cultures were incubated at 30ºC for 24 hours.  
Colonies were then replica plated onto YPG media to determine number of colonies that 
contained functional mitochondria.  The difference between the number of colonies that 
grew on the YPD plates and the number that grew on the YPG plates divided by the 
number of colonies on the YPD plates is the proportion of petite colonies. 
 
Strain Genotype Background Source 
JCY1 MATa/α hisD1 leuD20 lys2D0 ura3D0/ hisD1 
leuD20 met15D0 ura3D0 
BY4743 Research Genetics 
JCY2 MATa/α dap1∆::KanMX6/dap1∆::KanMX6 BY4743 Research Genetics 
Record No. 32082  
PGY11
 
 MATa/α ypr118w∆::URA3/ ypr118w∆::URA3 BY4743 Dr. Phillip Gray 
PGY21
 
 MATa/α  dap1∆::KanMX6 ypr118w∆::URA3/ 
dap1∆::KanMX6 ypr118w∆::URA3 




 Sensitivity Assay 
  
 Cells were streaked from glycerol stocks onto appropriate selective SD media and 
incubated at 30ºC for 24 hours.  Colonies were removed by scrapping and used to 
inoculate 10 mL YPD at 5x10
5
 cells/mL.  Cultures were grown at 30ºC, 220 rpm for 8 
hours.  Cell concentration was determined by direct cell count on a hemacytometer.  Cells 
were then serially diluted and spotted onto freshly prepared YPD +MMS plates.  The 










 cells per 
strain per different MMS concentration.  MMS was added to YPD plates to 0.005%, 
0.01%, 0.025%, and 0.05%.  
 Localization Assay 
 
 Transformed cells were incubated in a 0.035% MMS solution for the time points 
listed before fixation and subsequent visualization.   
 
 





Cells were streaked from glycerol stocks onto selective minimal SD media, 
specific for each strain, and incubated at 30ºC overnight.  A fresh colony was then 
transferred to a microcentrifuge tube containing 1 mL of water, subsequently diluted, and 
counted on a hemacytometer.  Cells were added to 1 L selective SD liquid media, in 2 L 
wide mouth flasks, to a cell density of 5x10
4
 cells/mL.  Cells were grown in SD media, a 
minimal media, to strictly observe sterol differences between the different strains.  Wide 
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At specified time points, in swirling flask, 5 x 1 mL of cells was removed, diluted, 
and counted directly on a hemocytometer.  An average of the 5 cell counts was used to 




Cells suspensions were transferred to 150ml Pyrex glass centrifuge tubes, 
centrifuged at 5,000 rpm for 10 minutes, in a Beckman rotor.  The supernatant was 
discarded quickly to prevent loss of cells, which is also why 10 minutes was used instead 
of the usual 5 minutes, to create a more compact cell pellet.  The process was repeated in 
the same glass tube until all of the original 1 L cell suspension was used.  The cell pellet 
was resuspended each time additional culture was added for centrifugation.  The final cell 
pellet was resuspended once in 30 mL PBS and centrifuged at 5,000 rpm for 10 minutes.  
The final cell pellet was resuspended in a minimal of PBS to form a viscous liquid.   
 
Total Lipid Extraction 
 
Lipids were extracted by the Bligh-Dyer (101) method, a more simplified version 
of the Folch (102) method. 
The total amount of resuspended cell volume in H2O was estimated using 
identical glass centrifuge tubes with known volumes of water.  Distilled methanol and 
distilled chloroform were added directly to the cell suspension in a 10:5:4 ratio of 
MeOH:CHCl3:H2O.  This ratio created a miscible solution.  If partitioning of layers was 
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noticed after a few minutes, methanol was added in 0.25 mL increments until no solution 
partitioning was observed.  This was followed by addition of chloroform to correct the 
MeOH:CHCl3 ratio to10:5.  The final volume of each solvent was recorded.  At this 
point, two surrogate standards (1.25 mg each) were added to each sample, estrone and 
cholesterol acetate.  These standards were used because of low price, ready availability, 
and retention time on the GC column so as to not interfere with sterol peaks.  Better 
standards can certainly be found if price and time are of little importance.  Solution was 
swirled briefly, capped with aluminum foil, sealed tightly with a cap and left to sit 
overnight. 
Solutions were then centrifuged at 10,000 x g for 15 minutes to pellet cell debris.  
The supernatant was poured into a 250mL separatory funnel.  CHCl3 and H2O was added 
to bring the final ratio MeOH:CHCl3:H2O to 10:10:9.  The solution was swirled gently in 
the separatory funnel a few times to insure proper mixing; the glass cap was removed 
between mixing to release pressure.  The separatory funnel was allowed to sit capped 
overnight. This allowed two distinct layers to form.  The chloroform layer, containing the 
total lipid fraction, being on the bottom, was removed into a round bottom flask.  Another 
extraction was performed adding the same final amount of chloroform as before.  Only 
wait as long as two distinct layers form.  The chloroform fraction was removed and added 
to the first fraction. 
The chloroform solvent, containing the total lipid fraction, was evaporated to 
about 1 mL using a Buchi RE 111 rotavapor.  The chloroform solution was then 
transferred to a test tube.  The evaporation flask was washed 5 times with about 1.5 mL 
chloroform and transferred to the test tube.  The test tube, containing the total lipid 
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fraction, was put in a gently heated water bath 30º-40ºC, so as to not condense water 
under the evaporating conditions, under a fume hood and evaporated to almost dryness 
under N2 gas. 
The test tube was then transferred to a desiccation chamber and the solvent was 
completely removed under vacuum.  After complete solvent removal, N2 gas was slowly 
allowed to enter the chamber. While keeping the N2 flowing, and working as quickly as 
possible the desiccation chamber was opened and the test tube was removed. Two mL of 
distilled hexane was immediately added to the dry lipid fraction.  The process was 




Several glass chromatography columns were set up in a fume hood.  Oven dried 
Unisil (activated salicic acid, 200-325 mesh, Clarkson Chemical Company, INC, 
Williamsport, Pennsylvania) was added to about a 2 cm depth.  The Unisil was packed by 
gently tapping the column with a rubber stopper.  The column was then thoroughly 
washed inside and out with distilled hexane.  The column was tapped gently again to 
release any trapped gas bubbles in the stationary phase.  Before the hexane layer reached 
the top of the solid phase, the lipid fraction dissolved in hexane was added to the column.  
The test tube was washed 3 times with about 1.5 mL hexane and added to the column.  
The mobile phase was allowed to drip into a collection flask.  As the top of the mobile 
phase was about to reach the solid phase about 7 mL of distilled hexane was carefully 
added to the column.  The process was repeated 2 times until about 25 ml hexane was 
collected.   
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As the hexane mobile phase was about to reach the solid phase the benzene 
solution was added to the column.  The test tube was again washed 3 times with about 1.5 
mL benzene and added to the column.  A new collection flask was added to the bottom of 
the column.  As the top of the benzene mobile phase was about to reach the solid phase, 
10 mL benzene was carefully added to the column.  This process was repeated until about 
100 mL of benzene solution was obtained.  The process was then repeated with 
chloroform to about 100 mL and finally methanol to about 25 mL.   
The separate fractions were concentrated in a roto-evaporator, transferred to a test 
tube, taken to dryness under a stream of N2 at 30º-40ºC and immediately re-dissolved in 
0.5 mL distilled chloroform.  
The hexane portion contains aliphatic hydrocarbons.  The benzene portion 
contains aromatic hydrocarbons, fatty acid methyl esters, and steryl-esters.  The 
chloroform portion contains free fatty acids, free sterols, triglycerides, diglycerides, and 
monoglycerides.  The methanol portion contains glycolipids and phospholipids. The two 
surrogate standards added, estrone and cholesterol acetate, partitioned with the free sterol 
fraction and the steryl ester fraction, respectively.   
 
Determination of Free Sterol vs. Steryl-Ester Separation 
 
 
To establish that the free sterols were separated from steryl esters, TLC (thin layer 
chromatography) was performed.  Commercially prepared TLC plates were used, Silica 
Gel G, 20 x 20 cm plates.  The plates were heat activated at 120ºC overnight, allowed to 
cool briefly before use.  Separate solvent components were spotted on the TLC plates in 
the 100-300 µg range.  Plates were immediately developed after application of sample.   
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A glass tank (11 x 21 x 21 cm) with a ground glass cover and lined with filter 
paper on three sides, to aid in saturating the tank with solvent vapor, was used.  Two 
tanks were prepared, the first, tank #1, with a polar solvent mixture and the second, tank 
#2, with non-polar solvents.  The polar solvent mixture consists of diethylether : benzene 
: ethanol : acetic acid (45:50:2:0.2), the non-polar solvent mixture consists of hexane : 
diethylether (96:4). 
The polar tank was prepared first and allowed to equilibrate for 30 minutes prior 
to use.  The TLC plate was then placed in tank #1 and the solvent allowed to run about 
5/8ths of the way up the TLC plate.  The solvent front was marked by making a thin 
scrape along the edge of the TLC plate.  The TLC plate was then dried inside a box 
flushed with N2 gas, until no acetic acid could be smelled on the TLC plate.  While the 
TLC plate dried the second tank was prepared and allowed to equilibrate. The TLC plate 
was then placed in tank #2 and the solvent allowed to run to the top of the TLC plate.  
The TLC plate was allowed to dry briefly again inside a box flushed with N2 gas.   The 
components of the TLC plate were visualized by exposing the TLC plate to iodine 
vapors.  This was accomplished by placing the TLC plate inside a glass tank containing 
iodine crystals.  All components of the TLC plate that are potential proton donors will 
stain a yellowish-orange.  A permanent record was obtained by placing a clean glass plate 
over the chromatogram, tracing the spots with a felt pen, then subsequent photocopying.  









: dap1∆-hexane fraction; 4
th





: control-chloroform fraction; 7
th





: dap1∆-methanol fraction. 
FS: free sterols; MG: monoglyceride; FA: free fatty acid; DG: diglyceride; TG: 
triglyceride; KE: ketone; ME: methyl ester; SE: steryl ester. 
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Saponification of sterol fractions 
 
The benzene portion, containing the steryl-ester fraction, and the chloroform 
portion, containing the free sterol fraction were reduced to dryness under N2 gas at 30-
40ºC.  Next, 2.5 mL of 2.5% HCl:Methanol (W/V) was immediately added to each test 
tube.  The HCl:Methanol was prepared by bubbling 2.5 g HCl gas into 100 ml anhydrous 
methanol, prepared by distillation.  The test tubes were capped tightly and put in an 80º-
90ºC oven for 1 hour.  The solutions were then dried to almost completion under a stream 
of N2 gas at 30º-40ºC, then put into a desiccation chamber and dried to completion under 
vacuum.  Samples were removed from the desiccation chamber as before and the sample 
was immediately redissolved in 0.5 mL chloroform.   
 
Addition of Internal Standard 
 
Samples in CHCl3 were transferred to 2 mL amber vials with Teflon caps, dried 
under N2, and then 0.35 mL chloroform was added immediately to the vials.  Next, 0.1 
mL of cholesterol (1mg/mL in chloroform) was added to the free sterols samples and 0.1 
mL estrone (1 mg/mL in chloroform) was added to the steryl ester samples.  
 
Derivitization of sterol fractions 
 
For derivitization, 0.05 mL of N,N-Bis(trimethylsilyl)acetamide (TMS) was 
added to each sample.  To bring the total volume of each vial 0.5 mL.  The caps were put 
on the vials tightly then placed in an oven set to 80º-90ºC for 15 minutes.  Samples were 
allowed to cool, evaporated under a stream of N2 gas at 30º-40ºC to about half the 





Gas chromatography was performed using a Hewlett Packard 5890 gas 
chromatograph equipped with an SGE HT5 polyimide clad column (12 m x 0.22mm ID x 
0.1 µm), and flame-ionization detector.  The detection signal was recorded on an 
HP3394A integrator.  The column head pressure was set to 8psi, the carrier gas (He) was 
set at 30 psi and all injections were operated in the splitless mode.  The injector was set to 
300ºC and the FID was set to 320ºC.  The program was as follows: oven initial 




 at a rate of 8
o
/min, and maintained 
at the upper temperature for 5 min.  Based on standards, estrone (Sigma) was known to 
elute at 10.06 min., cholesterol (Sigma) at 13.83 min., ergosterol (Sigma) at 14.32 min, 
and lanosterol (Sigma) at 15.44 min. using this particular program.  Sterols were 
identified by comparing the retention times of established commercial standards injected 
into the GC as well as by GC/MS at the Georgia Tech Mass Spectroscopy Lab.  Samples 
were each injected twice and the average of the quantities was used for data.  Each 
morning before use, the injector column was lightly cleaned with chloroform and 
methanol and a new septum added to the injector port. 
 
Quantitation of Sterol Content 
 
Quantitization of sterol content was determined by the extraction efficacy based 
on the area of the surrogate standard peak, area of the internal standard peak, and finally 





Difficulties in procedure 
One of the serious problems in isolating lipids is the easy acquisition of 
contaminating material.  The most common sources of extrinsic lipids are soap, organic 
solvents, and plastic products.  All glassware were chemically cleaned, thoroughly rinsed 
with water, methanol, and then dried in an oven reserved for clean glassware.  Prior to 
use glassware was washed with methanol and chloroform and allowed to dry upside 
down in a fume hood.  All solvents were freshly redistilled before use, except benzene, 
which was considered too hazardous to distill.  Most glassware was equipped with 
tapered joints; screw cap tubes were Teflon lined.  Extreme care was exercised with all 
equipment, chemicals, and glassware to prevent contamination from handling and 
experimental manipulation during the course of the analyses. 
Sterols themselves are degradable.  They should not be exposed to oxygen, 
particularly when in dried form.  They should be stored in light restrictive containers.  
Sterols also have some affinity to stick to glass.  Therefore, it was necessary when 
transferring sterol solutions from one container to another, that the sides of the glass 
container were washed with solvent at least 3 times, preferably 5 times with the 
appropriate solvent, usually chloroform.  This procedure was most critical immediately 
prior to injection into the GC.  Standard operating procedure was to cap the vial tightly 
and to place it on top of the GC oven, which heats the chloroform enough for it to 
evaporate.  The chloroform condensed at the top of the vial and droplets formed and roll 
down the sides of the vial, picking up any residual sterols stuck to the sides.   
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 Consistent results were only obtained when fresh colonies were streaked onto 
selective synthetic plates from glycerol stocks.  Transformation was carried out thusly 
with fresh colonies and used immediately after transformation.   
 
Mammalian Cell Line Transfection 
 
 Hpr6.6 was cloned into the vector pEGFP-N1 (Clonetech) by Dr. Hosoon Choi of 
our lab, for making EGFP fusion protein under the control of the CMV promoter.  The 
fusion protein plasmid was transfected into HeLa cells using calcium phosphate 
transfection.  Briefly, 9mL of DMEM media [Dulbecco’s modified Eagle’s medium, 10% 
fetal bovine serum, 4.5 g/L glucose, 7.42 g/L L-glutamine] was transferred to a 10 cm 
dish.  About 5x10
5
 HeLa cells were added drop-wise into the dish containing sterile 
12mm No. 1 glass circle cover slips.  The cover slips, with adhered HeLa cells, were 
moved to 12 well plates 24 hours after plating.  1 mL of DMEM media was added to each 
well.  DNA/CaPO4 mix (2 µg of high purity DNA + 8 µL of 2 M CaCl2, and dH20 to 
make total volume 62.5 µL) was prepared in 10mL sterile culture tubes.  62.5 µL of 2X 
HBS (280 mM NaCl, 10mM KCl, 1.5mM Na2HPO4, 12 mM glucose, 50mM HEPES, 
pH 7.05) was added to the tube while vortexing.  DNA/CaCl2/HBS mixture sat at room 
temperature for 10 minutes.  The mixture was vortexed again, and then the entire mixture 
was added drop-wise over the plate of cells.  The cells were then incubated overnight.  
The next day, the plates were gently swirled and the media aspirated off.  The cells were 
washed 3 times with PBS, pH 7.4.  Fresh media was added and the culture returned to 
incubation.  The next day, cells were washed 3 times with PBS, pH7.4, fixed with 4% 
formaldehyde, and placed on a glass slide cell side down. 
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Construction of DAP1 and Ypr118w plasmids 
 
 
Construction of DAP1 in pUGpd.  DAP1 was PCR amplified using the 
oligonucleotides YPL170W1 (5’-CGGGCCATGGCACACACACGTACATCGGAAT-
3’) and YPL170W2 (5’-GGCGGTCGACATAATGTGCGGAGCTCAATCG-3’).  The 
resulting 500 bp fragment was cloned into the T-vector pCR2.1 (In Vitrogen).  DAP1 was 
removed using SpeI/XbaI and ligated in the SpeI/XbaI site of pUGpd (courtesy of Dr. 
Susan Lindquist), a constitutive expression vector containing the Gpd promoter [85].  
Construction was performed by Dr. Phillip Gray, Georgia Institute of Technology. 
 
Construction of YPR118w in pUGpd.  YPR118W was PCR amplified using the 
oligonucleotides YPR118W-5’ (5’-CTGCTGACAAACCATGGCGTTGG-3’) and 
YPR118W-3’ (5’-GGTTATAGTGTTGTCGACTTACAAGG-3’).  The resulting 1400 bp 
fragment was cloned into the T-vector, pCR2.1 (In Vitrogen).  YPR118W was removed 
by performing a limited digest with SpeI (YPR118w contains a SpeI site at 800 bp) and 
full digest with XbaI and ligated in the SpeI/XbaI site of pUGpd.   Construction was 
performed by Dr. Phillip Gray, Georgia Institute of Technology. 
 
Construction of DAP1 in pHGPD-sGFP.  DAP1 was PCR amplified using the 
oligonucleotides YPL170W-GFP5’ (5’-AAATCTCATCAGCCACACACA-3’) and 
YPL170W-GFP3’ (5’-ACGCCAGGCTCTAGAATCAGA-3’) containing an XbaI site.  
The resulting 500 bp fragment was cloned into the T-vector, pCR2.1 (In Vitrogen), 
subsequently removed using SpeI and XbaI and ligated into the SpeI/XbaI site of 
pHGPD-sGFP (courtesy of Dr. Susan Lindquist).  The pHGPD-sGFP contains the Gpd 
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promoter, which allows constitutive expression of the GFP fusion protein.  Construction 
was performed by Dr. Phillip Gray, Georgia Institute of Technology. 
 
Construction of the pUGpd-RFP vector.  The MCS and red fluorescent protein 
were cut out of pDsRed1-N1 (Clontech) using BglII and NotI and cloned into the 
BamHI/NotI site of pUGpd.  The pUGpd-RFP vector also contains the Gpd promoter, 
allowing for constitutive expression of RFP fusion proteins.   
 
Construction of YPR118w in pUGpd-RFP.  YPR118W was PCR amplified 
using the oligonucleotides 118 RFP 5’ (5’- AATATCTACGCCCGGGAAAGT-3’) 
containing a XmaI site and 118 RFP 3’(5’-TTCACCACCGGTATTTTTGG-3’) 
containing an AgeI site.  The resulting 1200 bp fragment was cloned into the T-vector, 
pCR2.1 (In Vitrogen), subsequently removed using XmaI and AgeI and cloned into the 
XmaI /AgeI site of pUGpd-RFP. 
 
 
Construction of pUGpd-Ypr118w-RFP2.  Since the RFP1 protein had been 
shown to sometimes aggregate with itself, a construct was made using the new pDsRed2-
N1 plasmid (Clontech).  The RFP protein was removed from the pUGpd-YPR118W-RFP 
plasmid using AgeI and NotI, using limited digest since the ypr118wp includes an AgeI 
site.  The DsRed2 protein was cut out of pDsRed2-N1 also using AgeI and NotI and 
cloned into the AgeI/NotI site of pUGpd-YPR118W-RFP. 
 
Construction of ypr118w-RFP2 in pRS315.  To allow for co-localization with 
pHGPD-DAP1-sGFP, which contains a HIS3 marker, in the double mutant strain, the 
Gpd promoter along with the YPR118W-RFP2 fusion construct was cloned into pRS315, 
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which contains a LEU2 marker.  The Gpd promoter along with the YPR118W-RFP2 
fusion construct was cut out of  pUGpd-ypr118w-RFP2 using ApaI and NotI and cloned 
into the already cut Apa1/NotI sites of the pRS315 plasmid (courtesy of Dr. Susan 
Lindquist). 
 
Construction of pmCUP1-Hpr6.6.  Hpr6.6 was PCR amplified from pEGFP-N1 
containing full length Hpr6.6 fused to the N-terminal of EGFP, using oligonucleotide 
cup1-hpr6.6-fwd (5’-CCGCTCTAGAATGGCTGCCGAGGATGTGGT-3’) containing a 
NotI site, and oligonucleotide cup1-hpr6.6-rev (5’-
GCGGCGCCTTAATCATTTTTCCGGGCACTCTC-3’)containing a XbaI site.  The 
PCR product was ligated into pGEM T-vector, cut with NotI and XbaI and ligated into 
the NotI/XbaI site of pmCUP1 containing a copper promoter. 
 
Construction of pmCUP1-Hpr6.6-GFP.  Hpr6.6 was PCR amplified from 
pEGFP-N1 containing full length Hpr6.6 fused to the N-terminal of EGFP, using 
oligonucleotide cup1-hpr6.6-fwd (5’-CCGCTCTAGAATGGCTGCCGAGGATGTGGT-
3’)  containing a NotI site, and oligonucleotide cup1-hpr6.6gfp-rev (5’-
CTGCGGCCGCCATTTTTCCGGGCACTCTCA-3’)containing a XbaI site.  The PCR 
product was ligated into pGEM T-vector, cut with NotI and XbaI, and subsequently 




Transformed cells were grown overnight in SD medium, centrifuged, washed with 
PBS and resuspended in mounting medium (Fluoromount-G, Southern Biotechnology 
Associates).  For DAPI staining, 22.5µg/ml DAPI was added directly to mounting media.  
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For lipid particle staining, cells were incubated with nile red (Sigma) at 10 µg/ml for 10 
minutes, then washed with PBS x 3 prior to resuspension in mounting medium.  Images 
were captured using a Zeiss LSM510 UV confocal laser scanning microscope with either 
a Zeiss 63X or 100X Plan-Neofluar oil immersion lens (Core Facilities at the Parker H. 











Cells of the control strain, the dap1∆ mutant strain, the ypr118w∆ mutant strain, 
and the dap1∆/ypr118w∆ double mutant strain were grown using YPD (Fig. 2-6), SLAD 
(Fig. 7-8), and SPHD (Fig. 9-10) media, as described in Materials and Methods.  Cell 
counts were determined at specified time points. 
 
Cell Growth in YPD Medium   
 In YPD medium, no significant differences in growth rate were observed between 



































Figure 2.  Cell growth in YPD.  Graph shows number of cells of the control strain (blue 
diamonds), the dap1∆ mutant strain (pink squares), the ypr118w∆ mutant strain (yellow 
triangles), and the dap1∆/ ypr118w∆ double mutant strain (green stars).  Cell number was 


















Competition Experiment in YPD Medium   
 For a more sensitive test of whether the deletion strains have a competitive 
disadvantage in long-term growth, we performed pairwise long-term competition 
experiments.  Fresh 10mL  
 In YPD medium, no obvious differences were observed between the control strain 
and the deletion strains, except at approximately 50 days and beyond, where the deletion 
strains marginally outgrew the control strain.  This was noted in Figures 3 and 4 by a 
proportional increase ranging from 10-15%.  Figures 5 and 6 show that for YPD, in the 
short term growth period, considered exponential growth phase, there are no considerable 
differences between the control and the deletion strains.  Therefore, neither the dap1∆ 
mutant strain nor the ypr118w∆ mutant strain appears to suffer from a growth 























Figure 3.  Long term Competition Experiment in YPD: control strain vs. dap1∆ mutant 
strain.  Colonies were counted and the proportion determined by the number of dap1∆ 



















Figure 4.  Long term Competition Experiment in YPD: control strain vs. ypr118w∆ 
mutant strain.  Colonies were counted and the proportion determined by the number of 



































Figure 5. Short term Competition Experiment in YPD: control strain vs. dap1∆ mutant 
strain.  Colonies were counted and the proportion determined by the number of dap1∆ 






































Figure 6. Short term Competition Experiment in YPD: control strain vs. ypr118w∆ 
mutant strain.  Colonies were counted and the proportion determined by the number of 























Competition Experiment in SLAD Medium   
 As a more stringent test, we performed competition experiments in synthetic, 
nitrogen-limiting media.  Nitrogen-limitation was chosen both because yeast in the wild 
usually face nitrogen limitations, and also because microarray expression data [114] 
indicated that DAP1 expression increased during nitrogen-limited growth.   
 In SLAD (nitrogen starvation) media, no obvious difference was observed 
between the control strain and the dap1∆ mutant strain in the first two weeks of culture, 
going from exponential growth to late log phase.  As the cells are transferred every 7 
days to fresh media, this pattern was continued for one more cycle.  But between the 
second and third media change and until the end of the experiment, the dap1∆ mutant 
strain exhibited a competitive advantage over the control strain in the SLAD medium.  
This is noted in Figure 7 by a proportional increase ranging from 70-95%.   
 The opposite outcome was observed between the control strain and the ypr118w∆ 
mutant strain.  No obvious difference was observed between the control strain and the 
ypr118w∆ mutant strain during the first cycle in SLAD medium.  But, during the second 
and subsequent media cycle changes, the ypr118w∆ mutant strain exhibited a much 
diminished competitive edge as compared to the control strain, in fact going extinct in the 
culture.  This was noted in Figure 8 by a proportional decrease ranging from 30 to 100%.  
The subsequent identification of Ypr118wp as an enzyme in the methionine salvage 

























Figure 7.  Long term Competition Experiment in SLAD (nitrogen starvation) media: 
control strain vs. dap1∆ mutant strain.  Colonies were counted and the proportion 
determined by the number of dap1∆ colonies verses total number of colonies.  Points 





































Figure 8.  Long term competition experiment in SLAD (nitrogen starvation) media: 
control strain vs. ypr118w∆ mutant strain.  Colonies were counted and the proportion 
determined by the number of ypr118w∆ colonies verses total number of colonies.  Points 



















Competition Experiment in SPHD Medium 
 We also performed competition experiments in SPHD, a medium that is less 
severely nitrogen-limiting than SLAD. 
 In SPHD media, no obvious differences were observed between the control strain 
and the dap1∆ mutant strain, except at approximately 50 days and beyond, where the 
dap1∆ mutant strains marginally outgrew the control strain.  This was noted in Figure 9 
by a proportional increase ranging from 10-20%. 
 In contrast, the ypr118w∆ mutant strain was outgrown by the control strain very 
early in the experiment. The control strain and the ypr118w∆ mutant strain seemed to 
reach and maintain equilibrium of approximately three control strain cells for every one 
ypr118w∆ mutant strain cell.  This was noted in Figure 10 by a proportional decrease 










































Figure 9.  Long term Competition Experiment in SPHD (low nitrogen) media: control 
strain vs. dap1∆ mutant strain.  Colonies were counted and the proportion determined by 
the number of dap1∆ colonies verses total number of colonies.  Points show the average 





































Figure 10.  Long term competition experiment in SPHD (low nitrogen) media: control 
strain vs. ypr118w∆ mutant strain.  Colonies were counted and the proportion determined 
by the number of ypr118w∆ colonies verses total number of colonies.  Points show 




















PHENOTYPIC GROWTH PATTERNS 
 
Frequency of Petite mutants 
 It was noticed that the dap1∆ mutant strain exhibited an increase in the number of 
petite colony formation during routine cell streaking from glycerol stock.  To determine if 
the colonies were actually petite or just exhibited prolonged slow growth, cells of the 
control strain, the dap1∆ mutant strain, the ypr118w∆ mutant strain, and the dap1∆/ 
ypr118w∆ double mutant strain were grown on YPD plates overnight and then replica 
plated onto YPG plates.  Those colonies that did not grow on the YPG plates were 
assumed to have lost mitochondrial function and classified as petite.  No further studies 
or characterization of the basis of mitochondrial loss was conducted.  Ten random 
colonies were scraped from the YPG plates, diluted, and used for the subsequent 
generations. 
 
Petite growth experiment 
 Colonies of the dap1∆ mutant strain and colonies of the dap1∆/ ypr118w∆ double 
mutant strain exhibited a higher proportion of petite colonies as compared to the control 
in the first generation of culture (see Figures 11 and 13).  Subsequent generations 
exhibited levels consistent with control levels.  Colonies of the ypr118w∆ mutant strain 















Figure 11.  Proportion of Petite Colonies of control strain grown in YPD for 3 






































Figure 12.  Proportion of Petite Colonies of the dap1∆ mutant strain grown in YPD for 3 






































Figure 13.  Proportion of Petite Colonies of the ypr118w∆ mutant strain grown in YPD 






































Figure 14.  Proportion of Petite Colonies of the dap1∆/ypr118w∆ double mutant strain 
grown in YPD for 3 generations.  Points show average of 3 independent experiments, 

























Methyl Methanesulfonate (MMS) Sensitivity Experiment 
 It had previously been reported [66] that the dap1∆ mutant strain exhibited an 
increased sensitivity to the DNA damaging agent MMS.  To verify this and to test the 
sensitivity patterns of the ypr118w∆ mutant strain, and the dap1∆/ ypr118w∆ double 
mutant strain an MMS sensitivity experiment was performed. 
 The dap1∆ mutant strain was more sensitive to MMS treatment than the control 
strain; this can most readily be seen in Figure 15 plates iii and iv.  The ypr118w∆ mutant 
strain acted similar to the control strain in MMS sensitivity; this can most readily be seen 
in Figure 15 plates iv and v.  The dap1∆/ ypr118w∆ double mutant strain was more 
sensitive to MMS treatment than the control strain, but exhibited a slightly less sensitivity 








Figure 15.  MMS Sensitivity Experiment.  Growth of serial dilutions from top to bottom 
on each plate: control strain, dap1∆ mutant strain, ypr118w∆ mutant strain, and 
dap1∆/ypr118w∆ double mutant strain on YPD media supplemented with MMS.  i) YPD, 
ii) YPD + 0.005% MMS, iii) YPD + 0.01% MMS, iv) YPD + 0.025% MMS, v) YPD + 









LOCALIZATION OF PROTEINS 
 
 
 DAP1-GFP and YPR118W-RFP2 fusions were constructed to monitor the sub-
cellular localization of the protein products in cells during vegetative growth.  DAP1 and 
YPR118W were cloned into different vectors with different selectable markers and fused 
to different colored fluorescent proteins; they were used to monitor their localization 
simultaneously in the same cell as well as independently in different deletion strains.  The 
DAP1-GFP and YPR118W-RFP2 fusion proteins were under the control of the 
constitutive promoter, Gpd.   
 
Dap1p-GFP Localization and Ypr118wp-RFP2 Localization 
 Dap1∆ mutant yeast cells and ypr118w∆ mutant yeast cells were transformed by 
the LiAc/PEG method with the plasmid pHGPD-DAP1-sGFP and pRS315-YPR118W-
RFP2, respectively.  Transformed cells were grown overnight in selective SD liquid 
media, centrifuged at 4,000 x g for 5 minutes, washed once with 1X TE, fixed with 3.7% 
formaldehyde, and resuspended in mounting media (1mg/ml p-phenylenediamine in 1X 
PBS 90% glycerol) containing 22.5ug/ml DAPI (4',6-Diamidino-2-phenylindole).  
Images were captured using a Zeiss LSM510 UV confocal laser scanning microscope 
with either a Zeiss 63X or 100X Plan-Neofluar oil immersion lens (Core Facilities at the 




Both Dap1p-GFP (Fig. 16-17) and Ypr118wp-RFP2 (Fig. 18-19) exhibited discrete 
particulate localization in the cytoplasm, and it appeared that Dap1p-GFP was also 
present in the ER. 
 To further characterize the Dap1p-Ypr118wp interaction, it was tested whether 
the absence of Dap1p would affect the localization of Ypr118wp-RFP2 and vice versa. 
Localization of Dap1p-GFP and Ypr118wp-RFP2 were monitored in the ypr118w∆ and 
dap1∆ mutant backgrounds, respectively, as well as in the dap1∆ /ypr118w∆ double 
mutant background.  The results showed the localization patterns of Dap1p-GFP and 
Ypr118wp-RFP2 are not dependent upon one another (data not shown).   
 In addition, Dap1p-GFP co-localizes with nile red, a stain specific for neutral 
lipids, and hence for lipid particles (Figure 20).  Lipid particles were also monitored in 
the dap1∆ mutant strain and in a strain over-expressing Dap1p (pUGpd-Dap1), to 
determine if the absence, or over production, of Dap1p influenced lipid particle 
formation, number or size.  No obvious differences were observed in the appearance or 
number of lipid particles in either the dap1∆ mutant strain, or in the strain over-













Figure 16. Dap1p-GFP localization experiment.  Left column were monitored in the 
green portion of the spectrum for acquisition of the GFP fluorescence.  Second column 
was monitored in the blue portion of the spectrum for acquisition of the DAPI stained 
nucleus fluorescing.  Third column was monitored in phase contrast for acquisition of cell 








A representative picture of the Dap1p-GFP localization experiment is shown below in 




Figure 17. Dap1p-GFP localization experiment, close-up.   
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Figure 18.  Ypr118wp-RFP2 localization experiment.   Left column was monitored in the 
red portion of the spectrum for acquisition of the RFP2 fluorescence.  Second column 
was monitored in the blue portion of the spectrum for acquisition of the DAPI stained 
nucleus fluorescing.  Third column was monitored in phase contrast for acquisition of cell 





A representative picture of the Ypr118wp-RFP2 localization experiment is shown below 










Figure 20. Dap1p-GFP localization with nile red stain.  Upper left panel was monitored 
in the red portion of the spectrum for acquisition of the nile red stain fluorescence.  Upper 
right panel was monitored in green for acquisition of GFP fluorescence.  These three 
pictures were merged to form the lower left panel. 
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Dap1p-GFP Localization with MMS Treatment 
 To determine if the Dap1p-GFP fusion protein exhibited differential localization 
upon addition of MMS (a DNA damaging agent), cells of the dap1∆ mutant strain were 
transformed with the pHGPD-DAP1-sGFP plasmid and incubated for various time points 
in YPD supplemented with 0.035% MMS.  The experiment showed an increase in the 
percentage of the Dap1p-GFP that localized peri-nuclearly (Figure 21 and Table 3).   
  Dap1∆ mutant yeast cells were transformed by the LiAc/PEG method with the 
plasmid pHGPD-DAP1-sGFP.  Transformed cells were grown overnight in selective SD 
liquid media, centrifuged at 4,000 x g for 5 minutes, and washed once with 1X TE.  Cells 
were then resuspended in 1mL YPD containing 0.035% MMS (v/v) for various time 
points, before being fixed with addition of formaldehyde to 3.7%.  Cells were then 
centrifuged and resuspended in mounting media (1mg/ml p-phenylenediamine in 1X PBS 
90% glycerol) containing 22.5ug/ml DAPI.  Images were captured using a Zeiss LSM510 
UV confocal laser scanning microscope with either a Zeiss 63X or 100X Plan-Neofluar 
oil immersion lens (Core Facilities at the Parker H. Petit Center for Bioengineering and 
Biosciences, Georgia Institute of Technology). 
 About 30 cells expressing the Dap1p-GFP fusion protein were picked at random 
at each time point for visualization and subsequent data storage.  After all data was 
gathered, pictures were then studied to determine if a merge existed between the blue of 
the DAPI stain and the green fluorescence of the Dap1p-GFP fusion protein.  If any 
amount of merge existed, the localization of the Dap1p-GFP fusion protein was termed 
peri-nuclear localized, even if some or most of the Dap1p-GFP fusion protein was 
localized to the cytoplasm; see Figures 21 and 22.   
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 Between 10 and 15 minutes after the addition of 0.0035% MMS, a greater 
percentage of the cells expressing the Dap1p-GFP fusion protein showed peri-nuclear 
localization rather than being exclusively localized to lipid particles as compared to 
transformed strain without the addition of MMS.  This higher percentage persisted for at 















































Figure 21. Dap1p-GFP localization experiment with addition of MMS.  Left column 
were monitored in the green portion of the spectrum for acquisition of the GFP 
fluorescence.  Second column was monitored in the blue portion of the spectrum for 
acquisition of the DAPI stained nucleus fluorescing.  Third column was monitored in 
phase contrast for acquisition of cell boundary and cell morphology.  These three pictures 







A representative picture of the dap1p-GFP with addition of 0.035% MMS localization 




Figure 22. Dap1p-GFP localization experiment with addition of MMS, close-up.   
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Table 3.  Percentage of Dap1p-GFP that show peri-nuclear localization. 
 
   Amount       Time            Number           Number    % 
 MMS(v/v)     (min)       Cytoplasmic     Peri-Nuclear         Total         Peri-Nuclear 
  None               0  28  8  36  22 
   0.035%   1  11  2  13  15 
   0.035%   5  22  7  29  24 
   0.035% 10  27  8  35  23 
   0.035% 15  20  12  32  38 
   0.035% 30  19  15  34  44 
   0.035% 60  20  11  31  35 
 


































Dap1p-GFP and Ypr118wp-RFP2 Co-localization Experiment 
 To reinforce the observation of the two-hybrid protein-protein interaction between 
Dap1p and Ypr118wp, performed by Dr. Phillip Gray (Georgia Institute of Technology), 
a co-localization experiment was performed in the dap1∆/ypr118w∆ double mutant yeast 
strain.  This experiment showed an overlap of localization between Dap1p-GFP and 
Ypr118wp-RFP2 (see Figures 23 and 24).  
 Cells of the dap1∆/ypr118w∆ double mutant yeast strain were co-transformed 
with pRS315-YPR118W-RFP2 and pHGPD-DAP1-sGFP according to the LiAc/PEG 
transformation protocol.  Transformed cells were grown overnight in selective SD liquid 
media, centrifuged at 4,000 x g for 5 minutes, washed once with 1X TE, fixed with 3.7% 
formaldehyde, and resuspended in mounting media (1mg/ml p-phenylenediamine in 1X 
PBS 90% glycerol) containing 22.5ug/ml DAPI.  Images were captured using a Zeiss 
LSM510 UV confocal laser scanning microscope with either a Zeiss 63X or 100X Plan-
Neofluar oil immersion lens (Core Facilities at the Parker H. Petit Center for 
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Figure 23. Dap1p-GFP and Ypr118wp-RFP2 co-localization experiment.  Four different 
co-transformed cells are shown to show the differences in protein distribution.  First 
column is detection in the red portion of the spectrum for cells expressing Ypr118wp-
RFP2. Second column is detection in the green portion of the spectrum for cells 
expressing Dap1p-GFP.  Third column is detection in the blue portion of the spectrum 
showing cells stained with DAPI, for DNA localization.  The fourth column is a merge.
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A representative picture of the co-localization experiment is shown below in large format 
for clearer viewing of localization. 
 
 
Figure 24. Dap1p-GFP and Ypr118wp-RFP2 co-localization experiment, close-up.   
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Transfection of HeLa cells with Hpr6.6p-EGFP 
 Hpr6.6p-EGFP fusion protein was constructed in the pEGFP-N1 plasmid 
containing the CMV promoter.  HeLa cells were transfected with this construct in order 
to determine the sub-cellular localization pattern of this protein during growth (Figure 
25).   
 Another localization study was done with Hpr6.6p-EGFP fusion protein with the 
addition of various amounts of MMS (0.05%, 0.1%, 0.5%, and 1%) for various time 
points (5min, 15min, 30min, 60 min, and 120min).  No obvious difference in the 
localization pattern was seen as compared to cells incubated in media lacking MMS (data 
not shown).  With the highest concentration of MMS for the longer time points, gross cell 


























Figure 25. Hpr6.6p-EGFP localization experiment in HeLa cells.  HeLa cells were 
transfected with Hpr6.6p-EGFP.  DNA was stained with Hoescht stain. Images were 
captured using a Zeiss LSM510 UV confocal laser scanning microscope with a Zeiss 63X 
Plan-Neofluar oil immersion lens (Core Facilities at the Parker H. Petit Center for 









STEROL IDENTIFICATION AND QUANTITATION 
 
 Yeast cells of the control strain and the dap1∆ mutant strain were grown, total 
lipids were extracted and free sterols were separated from steryl-esters, see pp. 17-25 in 
Materials and Methods.  Free sterols are sterols with only an alcohol group (hydroxyl) 
attached to the C-3 carbon in the A ring.  Steryl esters are sterol with a side chain, such as 
a long chain fatty acid or sugar moiety, that has been attached by an ester or glycosidic 
linkage bond to the C-3 carbon of the A ring and are therefore classified differently from 
free sterols.  The glycosidic sterols were not readily detected; thus no studies were done 
to quantify or identify the composition of these lipids.  After separation into free sterol 
and steryl esters any side-chain present was cleaved off in HCL: MeOH (15%v/w) 
leaving all sterols in the free sterol manifestation.  Sterol extracts were then derivitized 
with TMS and separated by gas chromatography.  Individual sterol peaks were identified 
by comparing the retention times to those of established commercial standards as well as 
by GC/MS at the Georgia Tech Mass Spectroscopy Lab.  
 Figure 26, page 91, exhibits a representative of the GC runs from each strain, 
fraction and experiment.  Figure 27, page 92, details the GC run between the control 
strain and the dap1∆ mutant strain.  The peaks are numbered in Figure 28, page 93, 
which corresponds to the peak numbers in the sterol tables. 
 
Mass Spectral Interpretation 
 
 
 The mass spectra of a large number of sterol TMS-ether compounds are available 
from mass spectral databases [107,108] and the fragmentation patterns of selected sterol 
compounds have been reported [109]. The molecular ion (M
+·
) provides the most 
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valuable information in the mass spectrum; it mass and elemental composition show the 
molecular boundaries into which the structural fragments indicated in the mass spectrum 
must be fitted.  The molecular ions of sterol TMS-ethers are very stable and have a high 









 and (M-side chain-TMSOH)
 +
.  
 The presence of the 3 -O-TMS group in sterols with a double bond in ring B can 
greatly enhance the cleavage of the adjacent C-C bond. The scheme below demonstrates 
the cleavage of the molecular ion into two fragments, each of which can retain the 
positive charge.  
 
 







 monounsaturated sterol TMS ethers exhibit the (M-129) 
+
 ion in higher 
abundances. In all other double bond isomers the abundance of the (M-129) 
+
 ion is l% or 
less. 
 Di-unsaturated sterol TMS ethers can also form a (M-129) 
+
 ion.  At  abundances 



















 [109].  Under 
certain conditions the (M-129) 
+
 ion can loose 2H
▪
 to form a tropylium ion derivative as 




                                                     Scheme 2 
 
Since the tropylium ion can only be formed if the two double bonds are located in ring B 




ion is observed in higher 









.   
Peak #1: 
 
 The mass spectrum of compound 1 exhibits a molecular ion at m/z = 466.  Major 
fragments are observed at m/z = 376 (M – TMSOH) 
+
, m/z = 361 (M – CH3 – TMSOH) 
+ 




, formation of tropylium ion (scheme 2).  Based on gas 
chromatographic retention data and comparison with mass spectra of authentic standards, 
peak 3 was identified as 3-trimethylsilyl-oxy-ergosta-5,7,22E,24(28)-tetraene 
(Ergostatetraenol).  
 
Peak #2:   
 
 The mass spectrum of compound 2 exhibits a molecular ion at m/z = 470, 
indicating 2 double bonds.  Major fragments are observed at m/z = 455 (M – CH3) 
+
, m/z 
= 380 (M – TMSOH) 
+
, and m/z = 365 (M – CH3 – TMSOH) 
+
.  The peak at m/z = 341 is 
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formed by loss of (M-129) 
+
 ion (scheme 1).   Among the possible structures for 























 .  
Peak #3:  
 
 The mass spectrum of compound 3 exhibits a molecular ion at m/z = 458. Major 
fragments are observed at m/z = 441 (M – CH3) 
+
, m/z = 366 (M – TMSOH) 
+
, and m/z = 
351 (M – CH3 – TMSOH) 
+
. The peak at m/z = 343 is formed by the loss of the side 
chain + 2H
▪
.  This fragment is observed in TMS sterol ethers which have unsaturation in 
their side chain.  Only after loss of 2H
▪ 
the (M – side chain) 
+
 ion can be stabilized by 
resonance (scheme 3). 
 
 
                                                    Scheme 3 
 
The position of the double bond in the side chain and the ring skeleton can not be 
determined from the mass spectrum. Based on gas chromatographic retention data and 
comparison with mass spectra of authentic standards, peak 3 was identified as 3-
trimethylsilyl-oxy-cholesta-8,24-diene (zymosterol).  
Peak #4: 
  
 The mass spectrum of compound 4, the additional peak in the dap1∆ mutant 
strain, exhibits a molecular ion at m/z = 466. Major fragments are observed at m/z = 451 
(M – CH3)
 +
, m/z = 376 (M – TMSOH)
 +




 and m/z = 
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. The m/z = 341 peak is formed via scheme 3 and 
indicates a 9 carbon side chain with two double bonds. The strong fragment at 251 is 
formed through consecutive loss of TMSOH, side chain and 2H
▪
. The position of the 
double bonds in the side chain can be assumed as 22E, 24(28) since ergosta-
5,7,22E,24(28)-tetraen-3-ol is the only intermediate in the ergosterol biosynthetic 
pathway which has two double bonds in the side chain. The positions of the two ring 
double bonds are uncertain, however, since no (M – 129) 
+
 ion (scheme 1) and no 
tropylium ion (scheme 2) is present.  Thus, certain isomers can be ruled out. These 
restrictions rule out ring A as a double bond carrier as well as ring B having two double 
bonds. Among the possible structures for compound 4 are 3-trimethylsilyl-oxy-ergosta-







.   
Peak #5: 
 
 The mass spectrum of the compound 5 exhibits a molecular ion at m/z = 468 and 
major fragment ions at m/z = 453 (M – CH3)
 +
, m/z = 378 (M – TMSOH)
 +
, m/z = 363 (M 
– side chain – 2H
▪









. Based on gas chromatographic retention data and comparison with mass 
spectra of authentic standards, compound 3 was identified as 3-trimethylsilyl-oxy-
ergosta-5,7,22E-triene (ergostosterol).  
Peak #6: 
 
 The mass spectrum of compound 6 has a molecular ion at m/z = 484 and major 
fragment ions at m/z = 469 (M – CH3)
 +
, m/z = 394 (M – TMSOH)
 +
, and m/z = 379 (M – 
CH3 – TMSOH, base peak)
 +
. There are no fragments which lost the side chain. The 
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compound was tentatively identified as 3-trimethylsilyl-oxy- 4,4-dimethyl-cholesta-8,24-
diene, based on the comparison of the mass spectrum of  a standard compound. 
Peak #7 and #8: 
 
 The mass spectrum of compound 7 and compound 8 were very similar in nature.  
They both possessed a molecular ion at m/z = 470 and major fragment ions at m/z = 455 
(M – CH3)
 +
, m/z = 380 (M – TMSOH)
 +
, m/z = 365 (M – TMSOH – CH3)
 +
, m/z = 343 








.  Based on 
previously reported GC data on similar columns and retention time compound 7 was 
assigned as 3-trimethylsilyl-oxy-ergosta-7,24(28)-diene (episterol) and compound 8 was 
assigned as 3-trimethylsilyl-oxy-ergosta-8,24(28)-diene (fecosterol).  
Peak #9: 
 
 The mass spectrum of compound 9 exhibits a molecular ion at m/z = 468, and 
major fragment ions at m/z = 453 (M – CH3)
 +
, m/z = 378 (M – TMSOH)
 +
, m/z = 363 
(M – side chain – 2H
▪




. Based on gas 
chromatographic retention data and comparison with mass spectra of authentic standards, 
peak 3 was identified as 3-trimethylsilyl-oxy-ergosta-5,7,24(28)-triene (ergostatrienol).  
Peak #10: 
 
 The mass spectrum of the compound 10 exhibits a strong molecular ion at m/z = 
474 and fragment ions at m/z = 459 (M – CH3)
 +
 and m/z = 384 (M – TMSOH)
 +
.  The 
molecular ion suggests a completely hydrogenated sterol. There are no significant ions 
present at M – side chain or M – TMSOH – side chain. Therefore two structures are 
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 The mass spectrum of the compound 11 exhibits a molecular ion at m/z = 498, an 
fragment ion at m/z = 483 (M – CH3) 
+ 
and m/z = 393 (M – CH3 – TMSOH, base peak)
 +
.  
Based on gas chromatographic retention times and mass spectral data compound 31 was 




 The mass spectrum of compound 12 exhibited a molecular ion at m/z = 466, and 
fragments at m/z = 451 (M – CH3)
 +
, m/z = 376 (M – TMSOH, base peak)
 +
 and m/z = 
339 (M –127) 
+
.  This last fragment is a mystery, since with a molecular ion at m/z = 466, 
there should be 4 double bonds present, with 2 in the side chain. It seems this compound 
had only one double bond in the side chain and 3 in the ring system.  Therefore, the 
fragment ion (M-127)
 +




.  The latter 
fragment is typical for sterols with unsaturated side chains.  The position of the double 
bond in the side chain is uncertain, it can be either 22E or 24(28), since both positions are 
present in the side chain of compounds in the ergosterol biosynthetic pathway. The 
positions of the three ring double bonds are uncertain, also. Since no (M – 129)
 +
 (scheme 
1) and no tropylium ion (scheme 2) are present certain isomers can be ruled out. 
Component 12 is a 3-trimethylsilyl-oxy-ergosta-tetraene isomer.   
Peaks #13 and #14: 
 
 Both compounds have similar fragmentation patterns. There was a molecular ion 
at m/z = 498, and fragment ions at m/z = 483 (M – CH3)
 +




. These are the major fragment ions expected from a lanosterol isomer, thus 
compounds 13 and 14 are ring double bond isomers of 3-trimethylsilyl-oxy-lanosta-24-
diene.  
Peak #15 and Peak #16: 
 
 The mass spectrum of compounds 15 and 16 exhibit very similar spectra both 
containing a molecular ion at m/z = 472, major fragments at m/z = 457 (M – CH3, base 
peak)
 +
 and minor fragments at m/z = 382 (M – TMSOH)
 +
, m/z = 367 (M – TMSOH– 
CH3)
 +









.  A molecular ion at m/z = 472 gives one double bond, furthermore, the position of 
the double bond is in the side chain, because of the presence of m/z = 345 and m/z = 255.  
Therefore, these are positional isomers of each other with one possessing the double bond 
at 22E and the other at 24(28), these compounds are identified as 3-trimethylsilyl-oxy-
ergosta-ene.  Since, the position of the double bond in the side chain cannot be 
determined it is unknown which peak corresponds to which compound. 
Peak #17: 
 
 The mass spectrum of peak 17 consists of three components, which could not be 
resolved by the gas chromatographic column. Component 1 has a molecular ion at m/z = 
498 and fragment ions typical for lanosterol-TMS, thus component 1 is a ring double 
bond isomer of 3-trimethylsilyl-oxy- ergosta-22,24(28)-tetraene.  Component 2 exhibited 
a molecular ion at m/z = 472. Fragments are observed at m/z = 457 (M – CH3)
 +
, m/z = 
382 (M – TMSOH)
 +
, m/z = 367 (M – CH3 – TMSOH)
 +
 and minor fragments at m/z = 
345 (M – side chain)
 +
 and m/z = 255 (M – TMSOH – side chain)
 +
. These two fragments 
establish a side chain with 9 carbons. Since there is no double bond in the side chain, the 
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two fragments that have lost the side chain are of low intensity. An (M – 129)
 + 
fragment 
was absent (scheme 1) which ruled out certain positions of the ring double bond.  
Comparison with the mass spectra of mono unsaturated sterol TMS ethers identified the 
compound as 3-trimethylsilyl-oxy- ergost-8(14)-ene.   Component 3 exhibited a 
molecular ion at m/z = 530, and fragment ions at m/z = 515 (M – CH3)
 +
, m/z =.425 (M – 
CH3 – TMSOH)
 +





 In summary, the major sterol peaks that were identified in this investigation were 
ergosterol; lanosterol; zymosterol; fecosterol; episterol; ergosta-5,7,22,24(28)- tetraen-
3β-ol, ergosta-5,7,22-trien-3β-ol; and 4,4-dimethyl-cholesta-8,24(28)-dien-3β-ol.  In 
addition to the identified sterols, there were numerous compounds that were detected in 
relative small quantities, with a few exceptions, that could not be identified precisely.  
The unidentified compounds did not elute with any of the known sterol standard and may 
be metabolic intermediates of sterols.   The fragmentation pattern by GC/MS analysis did 
not have library matches.  The parent ions were in the same range as those of the 
identified sterols, but without definite fragmentation patterns that support a proposal to 
identify the molecules.  The available evidence suggests that these components are 
aberrant sterols that have arisen through double bond migration during the sterol 
synthesis process, or as artifacts created by the hydrolysis and the derivitization 
procedure.  
Sterol Profiles 
 Tables 5-8 shows the sterol content of the control strain and the dap1∆ mutant 
strain as µg/10
8
 cells and also as a percentage of total sterols.  The tables are divided by 
both strain type and sterol origin (free sterol or steryl ester).  Figures 29 - 34 present a 
graphical representation of the same data in µg/10
8
 cells, whereas Figures 35 and 36 
present the data as total sterol content; the addition of the free sterol fraction and the 
steryl ester fraction.  In order to study the total sterol content of each strain the individual 
sterols for each strain in both the free sterol fraction and the steryl ester fraction were 
summed.  For the control strain this sum was 2.77 and 2.89 µg/10
8
 cells for 1 and 2 day 




 cells for 1 and 2 day old cultures, respectively.  For the dap1∆ + pUGpd:DAP1 
strain this sum was 2.71 and 2.81 µg/10
8
 cells for 1 and 2 day old cultures, respectively.  
For the dap1∆ + pCUP1:Hpr6.6 strain this sum was 2.68 and 2.82 µg/10
8
 cells for low 
and high copper in 2 day old cultures, respectively.  And finally, for the control + 
pCUP1:Hpr6.6 strain this sum was 2.98 and 3.17 µg/10
8
 cells for low and high copper in 
2 day old cultures, respectively.   
1-day versus 2-day cultures 
 Looking at the free sterol fraction of the control strain, the relative composition of 
individual sterols in 2 day old cultures is different from the relative composition in 1 day 
old cultures.  The difference is not highly dramatic showing that, metabolically, there is a 
conservation of sterol production and distribution.  In some cases, such as ergosterol, 
ergosta-5,7,22,24(28)- tetraen-3β-ol, and ergosta-5,7,22-trien-3β-ol, the relative 
proportions exhibited a slight increase in proportion from 1 day old cultures to 2 day old 
culture.  Whereas, zymosterol, fecosterol, and 4,4-dimethyl-cholesta-8,24(28)-dien-3β-ol 
decreases from 1 day culture to 2 days of culture.  Similarly, some of the unidentified 
compounds also varied in relative quantity of the total sterol composition.   
 In the control strain, the steryl ester fraction represented about 35% of the total 
sterol pool in 1 day old cultures.  This increased to about 41% in 2 day old cultures.  The 
esterified sterols of the control strain are not direct percent conversions to the free sterol 
fraction.  There is an apparent selectivity for which sterols are esterified.  Most notably, 
ergosterol, which accounted for about 33% of the free sterol fraction, accounted only for 
8-9% of the steryl ester fraction.  Lanosterol and 4,4-dimethyl-cholesta-8,24(28)-dien-3β-
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ol made up about 13% each in the steryl ester fraction, while only representing about 5% 
and 2%, respectively, in the free sterol fraction.  
 Comparing the steryl esters of the control strain from 1 day old cultures to 2 days 
old cultures, ergosterol is present in almost equal proportions.  This holds true for most of 
the esterified sterols.  However, episterol, fecosterol, and ergosta-5,7,22-trien-3β-ol 
decrease in relative proportion by about 50%, 35%, and 25%, respectively.  Two 
unidentified compounds increased in relative proportion.  An ergosta-ene isomer 
(unidentified peak #16) increased by about 70%, making up the largest portion of the 
steryl ester fraction at 15.35% in 2 days of culture.  A ring double bond isomer of 
lanosta-24-diene (peak #14) also nearly doubled from 1 to 2 days of culture.  The fact 
that the relative quantities of the identified sterols in the free sterol fraction of the control 
strain are quantitatively greater than in the steryl ester fraction makes it unlikely that 
these differences are due to the methodology, the derivitization process, or from 
contamination from extrinsic sources.   
dap1∆ mutant strain versus control strain 
 The dap1∆ mutant strain exhibited a 10-12% decrease of total sterol content as 
compared to the control strain.  This decrease was due primarily to the steryl ester 
fraction; a 6-9% decrease occurred in the free sterol fraction, whereas a 16-17% decrease 
occurred in the steryl ester fraction.   
 Not only was there a decrease in total sterol content, but the dap1∆ mutant strain 
exhibited a significantly altered sterol profile.  The most striking differences were a 50% 
reduction in ergosterol and the presence of an additional sterol peak, identified as an 
ambiguous ergosta-traene isomer (peak #4), eluting just before ergosterol and accounting 
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for 12-13% of the sterols present in the free sterol fraction in the deletion strain.  This 
peak was only seen in the free sterol fraction of the dap1∆ mutant strain.  It was not 
detected in the steryl ester fraction, nor was it detected in the dap1∆ mutant strain when 
either DAP1 or Hpr6.6 was overexpressed. 
 The free sterol fraction of the dap1∆ mutant strain exhibited an overall 
consistency between 1 and 2- day old cultures in the relative proportions of the sterols 
present, with a few exceptions.  The most significant was zymosterol (peak #3) which 
increased by ~75% from 1 day old cultures to 2 day old cultures.  Also, zymosterol was 
the most abundant sterol present in 2 day old cultures accounting for ~20% of sterols 
present.  This increase in zymosterol was at the expense of  4,4-dimethyl-cholesta-
8,24(28)-dien-3β-ol  (peak #6) which decreased by  ~70%, ergosta-5,7,24(28)-trien-3β-ol 
(peak #9) by ~45%, ergosterol by ~19%, and a sterol identified either as 4-methyl-
cholestane-3β-ol or a fully hydrogenated ergosterol (peak #10), by ~32%.  The other 
sterols maintained a similar relative proportion from 1 day old cultures to 2 day old 
cultures.   
 The steryl esters of the dap1∆ mutant strain, in contrast, exhibited a greater 
variability in relative distributions between 1 and 2-day old cultures.  Ergosterol and 4,4-
dimethyl-cholesta-8,24(28)-dien-3β-ol decreased by about half each.  Episterol (peak #7) 
increased by ~200%, fecosterol (peak #8) increased by ~20%, and lanosterol (peak #11) 
increased by ~30%.  Looking at the ambiguously identified compounds, the most 
significant was an ergosta-diene isomer (peak # 2), which decreased to about 25% that 
present in 1 day of culture.  Also, a lanosta-24-diene isomer (peak # 14) increased by 
~90% and a lanosterol isomer (peak #13) increased by about 60%.   
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 Comparing the free sterol fraction of the control strain to the dap1∆ mutant strain, 
there were significant differences in the sterol distribution pattern.  The most striking 
difference, as mentioned before, was the presence of the additional ergosta-tetraene 
compound, peak #4, eluting just before ergosterol that accounted for 12-13% of the free 
sterol present in the dap1∆ mutant strain.  This peak was present in both 1 and 2 day old 
cultures only in the dap1∆ mutant strain, and only in the free sterol fraction.   
 Comparing 1 day old cultures of the free sterol fraction of the control strain to the 
dap1∆ mutant strain, the sum of the ergosta-tetraene peak and ergosterol (peak #5) almost 
matches the amount of ergosterol in the control strain.  The deletion strain showed a 
decrease in episterol and fecosterol by ~40% and ~60%, respectively, compared to the 
control strain.  On the other hand, the relative proportion of ergosta-5,7,24-trien-3β-ol in 
the dap1∆ mutant strain was over twice that of the control strain.  Also, ergosta-
5,7,22,24-tetraen-3β-ol was present in a small quantity in dap1∆ mutant strain, but it was 
not detected in the control strain.  There were only slight differences in the most of the 
other sterols present. 
 Comparing 2 day old cultures of the free sterol fraction of the control strain to the 
dap1∆ mutant strain, there was a greater change in some sterol.  Zymosterol was present 
in about twice the quantity in the dap1∆ mutant strain as in the control strain.  Ergosterol 
was diminished in the dap1∆ mutant strain to about 40% of control.  As described above, 
the sum of the ergosta-tetraene peak eluting near ergosterol and the ergosterol in the 
dap1∆ mutant strain, is only 25% less in the dap1∆ mutant strain in 2 day old cultures.  
4,4-dimethyl-cholesta-8,24(28)-trien-3β-ol was present in low quantities in each strain, 
but its relative proportion in the dap1∆ mutant strain was reduced to less than 20% of the 
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control strain at 2 days of culture.  Ergosta-5,7,22,24(28)-tetraen-3β-ol, which was also 
present in low quantities in each strain, it was present in the dap1∆ mutant strain at about 
twice as much as in the control strain.   
 Comparing the steryl ester fraction of the control strain to the dap1∆ mutant 
strain, there was also significant differences between the sterol profiles.  As with the free 
sterol fraction, there was also a much greater difference between 2 day old cultures than 
in 1 day old cultures. 
 Comparing 1 day old cultures in the steryl ester fraction of the control strain to the 
dap1∆ mutant strain, episterol and 4,4-dimethyl-cholesta-8,24(28)-trien-3β-ol exhibited 
the biggest difference between the strains.  Episterol was about four-fold higher and 4,4-
dimethyl-cholesta-8,24(28)-trien-3β-ol was present in about 2.5-fold higher in the control 
strain.   
 Comparing 2 day old cultures in the steryl ester fraction between the control strain 
and the dap1∆ mutant strain, almost all of the sterols exhibited significant changes.  Most 
significantly, ergosta-5,7,24(28)-trien-3β-ol and ergosta-5,7,22,24(28)-tetraen-3β-ol were 
present in nearly twice the proportion in the dap1∆ mutant strain as in the control strain. 
But, ergosterol, which was increased in the dap1∆ mutant strain in 1 day old culture, was 
reduced in the dap1∆ mutant strain to ~60% of the control strain in 2 day old cultures, an 
ergosta-diene (peak #2) was reduced to about 25% of the control.  An ergosta-ene isomer 
(peak #16) and an unidentified sterol (peak #17) also became reduced to about 50% of 
control levels, largely because these compounds increased 2-fold from 1 day to 2 day old 




 A rescue experiment was performed to see if the mutant sterol phenotype 
observed in the dap1∆ mutant strain could be restored upon the addition of Dap1p under 
the constitutive promoter Gpd.  See Tables 9-10 and Figures 29-36. 
 With the addition of Dap1p to the dap1∆ mutant strain, the total sterol content 
increased slightly.  The total sterol content was still lower than levels exhibited by the 
control strain, but higher than the levels exhibited by the dap1∆ mutant strain.  The total 
free sterol fraction was between the levels of the control strain and the dap1∆ mutant 
strain.  The total quantity of the steryl ester fractions matched the levels of steryl esters of 
the control strain.   
 Comparing the free sterol fractions among the dap1∆ +GPD:DAP1 reconstituted 
strain, the dap1∆ mutant strain, and the control strain, the most striking feature is that the 
ambiguous ergosta-tetraene (peak #4) eluting just before ergosterol, present in the dap1∆ 
mutant strain but not in the control strain, was eliminated in the dap1∆ +GPD:DAP1 
cells.  Ergosterol levels in the dap1∆ +GPD:DAP1 strain were intermediate between the 
dap1∆ mutant strain and control strain levels, whereas the fecosterol level (peak #8) were 
restored to control levels in the 1-day old cultures, but fell well below the control of 
deletion strain levels in the 2-day old cultures.  The dap1∆ +GPD:DAP1 strain showed 
markedly elevated levels of several free sterol peaks compared to either the control of the 
dap1∆ mutant strain.  These were ergosta-5,7,22,24(28)-tetraen-3β-ol (peak #1), an 
ambiguous ergosta-diene isomer (peak #2), ergosta-5,7,24- trien-3β-ol (peak #9), 
lanosterol (peak #11), an ambiguous ergosta-tetraene isomer (peak #12), an ambiguous 
lanosta-24-diene (peak #13), and an ambiguous ergosta-ene isomer (peak #16).  
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Conversely, the dap1∆+GPD:DAP1 strain had reduced levels, compared to either the 
control or the deletion strain, of zymosterol (peak #3), the sterol that may be either 4-
methyl-cholestane-3-ol or a fully hydrogeneated ergosterol (peak #10), and an 
unidentified sterol (peak #17). 
 Comparing the steryl ester fractions, of the dap1∆ +GPD:DAP1 strain had 
markedly elevated levels of two ambiguous sterols.  A sterol identified as either 4-
methylcholestane-3-ol or a fully hydrogenated ergosterol (peak #10) and an ergosta-ene 
isomer (peak #16) were present in the dap1∆ +GPD:DAP1 strain  at levels up to 3-fold 
higher than in either the control or the dap1∆ mutant strain.  In fact, these two peaks 
accounted for ~13% and ~28% of the total esterified sterols, respectively, in this strain.  
Two sterols were present in lower quantities, as compared to the control strain.  These 
were episterol (peak #7), which was present in ~20% of the amount present in the control 
strain in one-day cultures, an ambiguous ergosta-tetraene (peak #12), and ergosterol 
(peak #5). 
Hpr6.6 Homologue Experiment 
 Experiments were performed to test the effects of introducing Hpr6.6, the human 
homologue of DAP1, on the sterol profiles of the control strain and the dap1∆ mutant 
strain.  If Hpr6.6 has a similar role in human cells as Dap1p in yeast cells, then we would 
expect Hpr6.6 to be able to rescue the dap1∆ mutant phenotype and restore sterol profiles 
to resemble the control strain.  Hpr6.6 was under the control of the copper promoter, 
CUP1.  These data are shown in Tables 11-14 and Figures 31-34. 
 No significant differences were seen between the sterol profiles of the control 
strain with the addition of Hpr6.6 and the dap1∆ mutant strain with the addition of 
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Hpr6.6.  There was a slight increase in total sterol content as a result of Hpr6.6 
expression in both the control strain and the dap1∆ mutant strain.   
 The strains expressing Hpr6.6 showed a large increase in ergosterol in both the 
free sterol and steryl ester fractions.  This was true for both the control strain and the 
dap1∆ mutant strain.  Compared to the control strain there was about a 30-50% increase 
in ergosterol in the free sterol fraction and greater than 500% increase in the steryl ester 
fraction.  Relative to the dap1∆ mutant strain, ergosterol increased about 200% in the free 
sterol fraction and about 500% in the steryl ester fraction.   
 The dap1∆+CUP1:Hpr6.6 strain resembled the dap1∆+GPD:DAP1 strain in that 
both strains eliminated the ambiguous ergosta-tetraene isomer (peak #4) prominent in the 
parental dap1∆ mutant strain.  The two strains differed in that most of the free sterols that 
were increased relative to control in the dap1∆+GPD:DAP1 strain were either reduced or 
comparable to controls in the dap1∆+CUP1:Hpr6.6 strain.  The most prominent of these 
were fecosterol (peak #8) at day 1 of culture, lanosterol (peak #11), a lanosterol isomer 
(peak #13), and an ergosta-diene isomer (peak #2). 
 In the esterified sterols, the dap1∆+CUP1:Hpr6.6 strain differed from the 
dap1∆+GPD:DAP1 strain and the control strain in that the ergosterol was about 6-fold 
higher and most other sterols were significantly reduced.  Whereas the 
dap1∆+GPD:DAP1 strain contained greatly elevated levels of either 4-methylcholestane-
3β-ol or a fully hydrogenated ergosterol (peak #10) and an ergosta-ene isomer (peak 
#16), the dap1∆+CUP1:Hpr6.6 strain had reduced levels of these sterols relative to the 










Figure 27.  Magnified representative GC runs from the control strain and the dap1∆ 
mutant strain, free sterol and steryl ester fraction.  Large peak to the left of each GC run 
is the added standard cholesterol.  Con: control strain, dap1: dap1∆ mutant strain, FS: 









Figure 28. GC run peak numbers.  Large peak to the left of each GC run is the added 
standard cholesterol.  Notice the presence of extra peak # 4 in the dap1-FS run.   













































 Growth of cells of the dap1∆ mutant strain, the ypr118w∆ mutant strain, and cells 
of the dap1∆/ ypr118w∆ double mutant strain did not grow at a significantly different rate 
than cells of the control strain when grown separately in YPD medium, see Figure 2.  
Growth of cells of the dap1∆ mutant strain and the ypr118w∆ mutant strain did not 
outcompete the control strain in short term or moderately long term in YPD culture, see 
Figures 3-6.  YPD is a very nutrient rich media.  This environment does not allow for 
slight phenotypic defects in growth to become apparent.  Only after 50 days of culture 
was there a slight increase in the proportions of the dap1∆ mutant strain and the 
ypr118w∆ mutant strain as compared to control.  This change was noted after 14 days of 
continuous culture, in which no cells were transferred to fresh media.  Under such 
conditions, it is hard to tell if indeed the strains were acting metabolically similar to the 
initial culture or if any secondary mutations had occurred after so many generations. 
 The growth curves in SLAD media, conversely, exhibited a marked change in 
growth patterns.  SLAD media is a nitrogen starving media.  The dap1∆ mutant strain 
had a significant increase in growth in competition experiment, almost outcompeting the 
control strain altogether, see Figure 7.  After 15 days of culture, the percentage of the 
dap1∆ mutant strain ranged from about 70% to about 99% of cells in culture.   
 The growth of the ypr118w∆ mutant strain in SLAD exhibited almost the 
complete opposite pattern.  The control strain significantly outcompeted the ypr118w∆ 
mutant strain after about 7 days of culture, see Figure 8.  This continued until no cells of 
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the ypr118w∆ mutant strain were seen in culture.  This is perhaps not entirely unforeseen.  
Ypr118w has been known to have sequence similarity to the regulatory subunits of the 
eukaryotic initiation factor two beta (eIF-IIβ) which has been recently found to be a 
methylthioribose-1-phospate isomerase [86].  It is involved in amino acid metabolism, 
specifically the methionine salvage pathway.  It is required to grow on S-
methylthioadenosine in the absence of methionine.  It catalyzes the conversion of 5-
methylthioribose-1-phosphate into 5-methylthioribulose-1-phosphate. 
 The competition experiment in SPD, which is a low nitrogen media, demonstrated 
that this media had no significant effect on the growth rate of the dap1∆ mutant strain as 
compared to the control strain, see Figure 9.  Once again, only after about 50 days of 
continuous culture did the dap1∆ mutant strain exhibit a slight competitive edge over the 
control. 
 The growth of the ypr118w∆ mutant strain in SPD maintained its limitations in 
fidelity in a nitrogen limiting environment.  The ypr118w∆ mutant strain exhibited a 
significant reduction in its ability to compete with the control strain in this nitrogen 
limiting media, see Figure 10.  The proportion of cells of the ypr118w∆ mutant strain 
decreased until it seemed to stabilize around 25% of cells in culture.   
 
Petite growth experiments 
 
 It was observed that there were a greater number of small colonies from the 
dap1∆ mutant strain when streaked out from glycerol stock and incubated at 30ºC 
overnight.  These smaller colonies could be slow growers or they could have lost 
mitochondrial function.  Those smaller colonies that have lost mitochondrial function are 
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ambiguously assigned the characteristic of petite.  To test whether these cells were 
actually petite or to see whether the cells were just slow growing, a phenotypic 
experiment was performed.  The designation petite is related to loss of mitochondrial 
function.  Functional mitochondria are determined by the yeast cells ability to respire on 
a non-fermentable carbon source.  A number of mutations can account for this phenotype, 
with a different designation for each.  There can be mutations in the nuclear genome or 
mutation in the mitochondrial DNA, unknown mutations or specific known gene 
mutations.  A designation of Nfs
-
 is a general phenotypic description and denotes lack of 
growth on non-fermentable substrates.  Therefore, the phenotype of petite described here, 
should be designated as such, in the strict sense. 
 The sterol content of mitochondria has been reported to be, generally, low [64].  
In yeast, most of the mitochondrial sterol content is located in the inner membrane [1].  
During import into mitochondria, sterols have been detected in the contact sites between 
the outer and inner membranes, supporting an idea that these zones are sites for 
intramitochondrial lipid translocation [65].  Ergosterol translocation from cytosol to 
mitochondria was enhanced by the presence of a transfer protein at non-limiting 
concentrations, in vitro [65].  The transfer protein, phosphatidylserine transfer protein, is 
known to translocate sterols between isolated membranes, in vitro, and only hypothesized 
in vivo [64].   
It was not the purpose of the study to determine the genetic or biochemical nature 
of the cause for the cells becoming petite, only to determine if cells had lost 
mitochondrial function or were slow growers.  Therefore, a simple experiment was 
performed.  Cells from each strain were grown overnight on separate YPD plates and the 
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next day colonies were replica-plated onto YPG plates.  YPG is media containing 
glycerol as the only carbon source.  Cells without functioning mitochondria are not able 
to ferment on glycerol, and hence can not grow.  This would distinguish between slow 
growers and petites.  
The experiment demonstrated that there was about a two-fold increase in the 
number of petites in the dap1∆ mutant strain as compared to the control strain, see 
Figures 11 and 12.  This difference disappeared after the first serial transfer, implying 
that the growth medium composition played a role in petite formation.  Since, only those 
cells that were able to utilize glycerol were used for subsequent generations.  Cells of the 
ypr118w∆ mutant strain exhibited no significant difference from the control strain, see 
Figure 13.  This suggests a more active role for Dap1p than ypr118wp in respiration.  
Cells of the dap1∆/ypr118w∆ double mutant strain acted similar to cells of the dap1∆ 
mutant strain, exhibiting about a two-fold increase in petites over control strain, see 
Figure 14, reinforcing the possibility that Dap1p plays a more central role in respiration 
than Ypr118wp.   
It could be hypothesized that the reason for the increase in the loss of 
mitochondrial function, and therefore a greater number of petites in the dap1∆ mutant 
strain, has to do with an altered sterol makeup in the mitochondria.  Since, there is an 
altered overall sterol profile in the dap1∆ mutant strain, it is reasonable to assume there is 
an altered sterol profile in the mitochondria.  This could lead to a reduction of respiratory 
function.  Furthermore, a physical connection exists between Dap1p and mitochondria in 
yeast.  It has been demonstrated that Dap1p interacts with GUF1, a mitochondrial 
GTPase of unknown function [87].  GTPases specifically bind and hydrolyse GTP in a 
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cyclic mechanism that activates and inactivates the GTPase protein [88]. In this cycle, the 
GTPase passes through three conformational states [89]. Initially, the GTPase is inactive 
and is not bound to any nucleotide.  After binding GTP, the protein becomes active and 
changes conformation, so that it has a changed affinity for effector molecules or other 
enzymes.  GTP is then hydrolyzed simultaneously, with an effect being generated on the 
target of the GTPase.  Subsequently, GDP is released from the inactive GTPase, so that 
the protein returns to the empty state.  This cyclic reaction usually involves several other 
factors that either catalyze the hydrolysis step of the GTPase cycle or catalyze the release 
of bound GDP from the inactive state of the GTPase [90].  Guf1p function in the 
mitochondria is still unclear.   
 Furthermore, Ypr118wp has been demonstrated to interact with Atp14p [91].  
Ypr118wp has been demonstrated to interact with Dap1p through a yeast two-hybrid 
interaction and demonstrated to co-localize with Dap1p.  Atp14p is located on the 
mitochondria membrane and functions in respiration as subunit H in the ATP synthase 
complex [92].  F1F2 ATP synthase is responsible for the synthesis of ATP from ADP and 
Pi at the expense of the proton chemical gradient generated by the respiratory chain [93].  
The null mutant is unable to respire on glycerol as the only carbon source [92].  
 These two interaction coupled with an altered sterol profile could presumable 
account for the elevation in petite formation.  It is unclear how this proteins interact with 








Growth on MMS 
 
 It has been reported that haploid cells of the dap1∆ mutant strain are sensitive to 
treatment with MMS [66] and even hypersensitive by the same lab [103].  MMS is a 
DNA damaging agent.  It causes double stranded DNA to be methylated, causing the 
replication fork to stall during S phase, leading to double stranded DNA breaks.  To 
verify this sensitivity and to determine how cells of the ypr118w∆ mutant strain and cells 
of the dap1∆/ypr118w∆ double mutant strain reacted to treatment with MMS, a 
sensitivity experiment was performed.  It was observed that cells of the dap1∆ mutant 
strain are slightly sensitive, but not hyper-sensitive, to MMS treatment, see Figure 15.  
Cells of the dap1∆ mutant strain exhibited a slight sensitivity to media containing 0.01% 
MMS (v/v) and marked sensitivity to media containing 0.025% MMS (v/v) as compared 
to control cells grown on same media.  Cells of the ypr118w∆ mutant strain did not 
exhibit any significant deviation from cells of the control strain.  Cells of the 
dap1∆/ypr118w∆ double mutant strain were about equally sensitive as cells of the dap1∆ 
mutant strain. 
 One could propose the reason for this has to do with DNA damage repair, 
however further work would have to be done in this area to verify or specify this 
functionality for Dap1p.  It has been reported that Dap1p does in fact have some role in 
DNA damage repair [66], hence its name, that Dap1p is required in order to progress 
through the G1-S transition following MMS induced DNA damage.  Further evidence 
supports this view; it has been demonstrated that Dap1p interacts with Tfb1p [94], a 
component of the RNA polymerase II transcription initiation factor TFIIH, which is 
involved in nucleotide excision repair and transcription [95].   
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Localization of Proteins 
 
 Dap1p-GFP localizes to the cytosol; see Figures 16 and 17.  This protein was seen 
mostly in lipid bodies, which is consistent with previous studies done on Dap1p 
[22,66,69], but here evidence is presented that suggest it can also be localized to the E.R.  
The protein-GFP studies done at UCSF support this claim that Dap1p is localized to both 
lipid bodies and the ER [69]. Most of the enzymes involved in the ergosterol biosynthetic 
pathway are localized to the ER, but several of the enzymes are also localized to lipid 
particles, in particular, Erg1p, Erg7p, and Erg6p.  Also, there is evidence to suggest that 
Erg27p interacts with Erg7p in the ER and also in lipid particles.   The localization 
pattern of Dap1p-GFP, as seen under the confocal microscope, suggest that it can localize 
peri-nuclearly; see Figures 21 and 22.  Furthermore, it has been demonstrated that Dap1p 
interacts with Erg11p [96], a protein located on the ER.  Erg11p is an enzyme in the 
ergosterol biosynthetic pathway that functions as a squalene epoxidase, catalyzing the 
conversion of squalene into squalene epoxide.   
 Ypr118w-RFP2 localizes to the cytosol, is present in lipid bodies (see Figures 18 
and 19), and also co-localizes with Dap1p-GFP when the two proteins are expressed 
together; see Figures 23 and 24.  The co-localization is not mutually inclusive; there can 
be the presence of one protein without the presence of the other, but major overlap is 
seen.    
 Upon treatment of MMS, Dap1p-GFP is still localized to the cytosol, but a greater 
proportion became localized peri-nuclearly; see Figures 21 and 22.  The percentage 
seems to change between 10 and 15 minutes and the highest percentage seemed to be 
produced between 15 and 30 minutes of treatment with MMS, but was still apparent after 
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60 minutes of treatment; see Table 3.  Location was termed peri-nuclear and not nuclear 
since limitations do exist with the confocal; however overlap was seen on the confocal 
microscope.  The nucleus in yeast is about 1-2µm and the smallest focal cell of the 
confocal used is about 1µm.  Accordingly, overlap appears to have occurred between the 
two; however in reality they could be adjacent, and not coinciding.  The patterns of 
localizations of Dap1p-GFP exhibited in these yeast cells do not suggest the protein is 
localized to the nucleus, although overlap is indeed seen on the confocal microscope.   
 Hpr6.6 was localized on the ER in HeLa cells; see Figure 25.  Which is consistent 
with studies done with the porcine MAPR homologue, mPR, which localized on the ER 
[67,68].  Treatment with MMS did not cause any differential location as seen in the yeast 
MAPR homologue Dap1p-GFP.  The reason for this difference is unclear.  Perhaps, the 
reason is simply that Hpr6.6 is already located on the ER and not located in lipid bodies.  
Therefore Hpr6.6 does not need to translocate, in order to achieve its role, if any, in DNA 
damage response.  Or perhaps even simpler, it has nothing to do with DNA damage, even 
though its yeast homologue Dap1p does.  It is thought the trans-membrane region in the 




 As compared to the control strain the dap1∆ mutant strain exhibited a significant 
alteration of sterol profile.  The most striking noticeable difference was the appearance of 
an additional unidentified sterol peak very close in retention time to ergosterol.  Mass 
fragmentation pattern analysis identified this compound to have a molecular ion of m/z = 
466; an ergosterol skeleton with four double bonds.  Two of these double bonds were 
localized to the side chain, presumably the positions can be assumed as 22E, 24(28) since 
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ergosta-5,7,22E,24(28)-tetraen-3-ol is the only intermediate in the ergosterol biosynthetic 
pathway which has two double bonds in the side chain.  The localization of the two 
double bonds in the rings remains to be elucidated.  This peak disappears upon rescue 
with Dap1p under the constitutive promoter Gpd, and with the human MAPR homologue 
Hpr6.6 under the control of the copper promoter, CUP1.  Perhaps of particular 
importance, this compound was only present in the free sterol fraction and not the steryl 
ester fraction.  The question needs to be addressed as to why it is only present in the free 
sterol form.  Further experiments will need to be done in order to verify if the localization 
of this molecule is constant throughout the cell or specific to either the plasma membrane 
or to any internal membranes.  Also, the significance of the absence of Dap1p in the 
formation of this compound needs to be addressed.   
 As compared to the control strain the dap1∆ mutant strain exhibited an 11.8% and 
a 10.5% decrease in total sterol content for 1 and 2 day old cultures, respectively.  This 
decrease was mostly due to the steryl ester fraction which exhibited a decrease of 16.4% 
and 17.2% of sterol content for 1 and 2 day old cultures, respectively.  Not only was the 
total sterol content affected, but the profile of individual sterols was also affected.  In the 
free sterol fraction, the most significant changes include zymosterol which increased to 
almost double the amount in 2 day old cultures.  Fecosterol was decreased in the dap1∆ 
mutant strain.  In the ergosterol biosynthetic pathway, Erg6p catalyzes the conversion of 
zymosterol into fecosterol.   Erg6p is located in lipid particles, where Dap1p is 
predominantly located, which suggests a connection between Erg6p function and Dap1p.  
The fact that sterol conversion does not stop at zymosterol, suggest that Erg6p can 
function without the help of Dap1p, although in a reduced capacity.   
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 In the steryl ester fraction, the most significant differences were in the 
unidentified sterols, particularly peak #13, #14 which was increased in the dap1∆ mutant 
strain, and #16 which was decreased.  The significance of this notable change in the 
unidentified sterols remains to be elucidated.  Significant differences were also seen in 
ergosta-5,7,24,(28)-trien-3β-ol and ergosta-5,7,22,24,(28)-tetraen-3β-ol which were 
increased, ergosterol is also increased in 1 day old cultures, but decreased significantly in 
2 day old cultures.  These are the last three sterols in the ergosterol biosynthetic pathway.  
Couple this with a slight increase of ergosta-5,7,24,(28)-trien-3β-ol and ergosta-
5,7,22,24,(28)-tetraen-3β-ol in the free sterol fraction with a decrease of ergosterol, 
suggests the production of ergosterol is being hindered at the very last step in the 
pathway.  This also suggests that these intermediates were being stored instead of being 
used for membrane biogenesis.  The fact that esterified ergosterol was similar to the 
control strain in 1 day old cultures, but significantly decreased in 2 day old cultures 
suggests a lag time response for this process. 
 
Rescue Experiment  
 
 When Dap1p was expressed in the dap1∆ mutant strain under the constitutive 
promoter, Gpd, the sterol profile once again changed, but did not match the control strain 
exactly; see Figures 29 and 30.  Partial rescue of the altered sterol profile might be caused 
by two reasons; use of a constitutive promoter and plasmid loss.  The addition of Dap1p 
to the dap1∆ mutant strain was not done using its native promoter, but a constitutive 
promoter overexpressing DAP1, this difference in level could account for differences in 
sterol levels.  Also, DAP1 was introduced via a plasmid.  Evidence suggests up to 30% of 
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cells can achieve plasmid loss in liquid cultures even under stringent selective media.  
This is a more likely scenario as to why sterol levels did not match the control levels.  
With the addition of Dap1p, zymosterol levels decreased significantly and fecosterol 
levels increased, once again suggesting a connection between Dap1p and Erg6p.  
Lanosterol also increased significantly.  In the dap1∆ mutant strain, lanosterol levels 
matched the control strain very well in both the free sterol fraction and the steryl ester 
fraction.  Lanosterol production is under the control of Erg7p, which is also localized to 
lipid particles.  This suggests a connection between Dap1p and Erg7p.  In fact, in 1 day 
old cultures every sterol in the free sterol fraction was increased or maintained similar 
levels upon addition of Dap1p in the dap1∆ mutant strain, with the exception of 
zymosterol which was severely decreased.  This holds true for 2 day old cultures as well, 
with the exception of fecosterol, the sterol made directly from zymosterol.  Taking this a 
step further, Erg6p is the first enzyme in the ergosterol biosynthetic pathway that is not 
essential for viability, meaning that cells can survive with zymosterol and not ergosterol 
as the primary sterol.  This suggests zymosterol could possibly be used as an indicator 
sterol like ergosterol for sterol production; reduction of zymosterol levels could promote 
either enzyme transcription or post-transcriptional up-regulation of these enzymes 
through phosporylation, see references [97,98] for this kind of sterol regulation in 
mammalian cells.  This could explain why every other sterol was present in a greater 
quantity, when zymosterol was decreased. 
 In the steryl ester fraction, the most significant changes occur in the unidentified 
peaks #10 and #16, upon addition of Dap1p in the dap1∆ mutant strain.  Mass spectral 
analysis revealed unidentified peak #10 to have a molecular ion at m/z = 474, a 
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completely hydrated ergosterol skeleton, and unidentified peak #16 to have a molecular 
ion at m/z = 472, with one double bond in the side chain.  Most of the other sterols 
maintain very similar quantitative levels.  The significance that only these two peaks 
change significantly in the steryl ester fraction remains to be elucidated.   
 
Hpr6.6 Homologue Experiment    
 
 
 Upon addition of Hpr6.6 to the control strain and the dap1∆ mutant strain, there 
was a very significant increase in ergosterol levels in both the free sterol fraction and the 
steryl ester fraction, see Figures 31 and 32.  This accompanied a corresponding decrease 
in the quantity of all the other sterols, with a few exceptions.  Interestingly in the control 
strain, ergosta-5,7,24,(28)-trien-3β-ol; ergosta-5,7,22,24,(28)-tetraen-3β-ol; which are the 
last two sterols before ergosterol;  and 4,4-dimethylcholesta-8,24(28)-dien-3β-ol 
increased slightly.   This was mirrored in the dap1∆ mutant strain, with the exception of 
ergosta-5,7,22,24,(28)-tetraen-3β-ol.   
 The fact that Hpr6.6 does not mirror the role DAP1 has upon sterol synthesis 
perhaps has to do with the N-terminal transmembrane region in Hpr6.6, which Dap1p 
does not possess.  The N-terminal transmembrane domain may cause retention of Hpr6.6 






 Dap1p belongs to a family of proteins that, although it has not been rigorously 
demonstrated in vivo or in vitro, is strongly suggestive of binding to certain 
steroids/sterols.  Enzymes involved in the ergosterol biosynthetic pathway are located 
mostly in the ER, but some (Erg1p, Erg7p, Erg6p, and Erg27p) are also located in lipid 
bodies.  Steryl esters are stored in lipid particles.  Steryl ester hydrolases have the highest 
specific activity on the plasma membrane.  Steryl esters somehow arrive at the plasma 
membrane where they are hydrolyzed to form the free sterol manifestation.  It was not 
noticed that Dap1p-GFP localized to the plasma membrane.  But, it has been 
demonstrated that Dap1p interacts with Pma1p [99] a plasma membrane H
+
-ATPase that 
serves to regulate intracellular pH and generate the membrane potential across the plasma 
membrane [100].  The proteins and/or the process(s) that move the sterols from the ER to 
lipid bodies and back again, or from lipid bodies to the plasma membrane, or from the ER 
to the various cellular membranes are not known.  Furthermore, the elements responsible 
for the translational and post-translational regulation of the enzymes directly involved in 
ergosterol production are also largely unknown.   
 The data presented here demonstrate that Dap1p localized to lipid particles and 
suggest it also localized to the ER, both sites of sterol synthesis. The data presented in 
this study demonstrates that Dap1p was involved in sterol processing, although its 
specific role is unknown.  Two possible scenarios are proposed; one where Dap1p is 
involved in regulating the flux of sterols from one internal membrane to another, and 
another where Dap1p is involved in aberrant sterol pathways.   
 125 
 A number of structural isomers of known yeast sterols were identified in this 
study in both the control strain and to a greater extent in the dap1∆ mutant strain; see pp 
105-113.  Evidence for aberrant sterol production pathways in yeast has been recently 
verified [104].  The possible double bond positions in the aberrant sterols found in this 
study are consistent with the positions of the double bonds in the aberrant sterol 
pathways.  Further work needs to be done to determine if Dap1p is directly involved in 
these aberrant sterol pathways or if the absence of Dap1p causes the upregulation of these 






1. Zinser, E., Sperka-Gottlieb, C.D.M., Fasch, E.V., Kohlwein, S.D., Paltauf, F. 
and Daum, G., (1991) Phospholipid synthesis and lipid composition of subcellular 
membranes in the unicellular eukaryote Saccharomyces cerevisiae. J. Bacteriol. 
173:2026-2034. 
 
2. Zinser, E., Paltauf, F. and Daum, G., (1993) Sterol composition of yeast 
organelle membranes and subcellular distribution of enzymes involved in sterol 
metabolism. J. Bacteriol. 175:2853-2858. 
 
3. Clark, L.H., Watson, C., Upchurch, S., McCormack, S., Padykula, H., 
Markaverich, B., and Hardin, J.W., (1980) Estrogen action in normal and 
abnormal cell growth In McLachlan J.A. Ed. Estrogen in the Enviroment. 
Amsterdam: Elsevier North Holland, Inc., p53. 
 
4. Mangeisdorf, D.J., Thummel, C., Beato, M., Herrlich, P., Schutz. G., Umesono, 
K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., and Evans, R.M., 
(1995) The nuclear receptor superfamily: The second decade. Cell 83:835-839. 
 
5. Groner, B., Hynes, N.E., Rahmsdorf, U., and Ponta, H., (1983) Transcription 
initiation of transfected mouse mammary tumor virus LTR DNA is regulated by 
glucocorticoid hormones. Nucleic Acids Res. 11:4713-4725. 
 
6. Parks, L.W., (1978) Metabolism of sterols in yeast. CRC Crit. Rev. Microbiol. 
6:301-341. 
 
7. Seyle, H., (1941) Anaesthetic effects of steroid hormones. Proc Soc Biol Med. 
46:116-118. 
 
8. Falkenstein, E, Norman, A.W., and Wehling, M., (2000) Mannheim 
classification of nongenomically initiated (rapid) steroid actions. J Clin Endocr 
Metab. 85:2072-2075. 
 
9. Evans, R.M., (1998) The steroid and thyroid hormone receptor superfamily. 
Science 240:889-895. 
 
10. Williams, S.P., and Sigler, P.B., (1998) Atomic structure of progesterone 
complexed with its receptor. Nature 393:392-396. 
 
11. Blackmore, P.F., Beebe, S.J., Danforth, D.R., and Alexander, M., (1990) 
Progesterone and 17 alpha-hydroxyprogesterone.  Novel stimulators of calcium 
influx in human sperm. J. Biol. Chem.  265:1376-1380. 
 127 
 
12. Turner, K.O., and Meizel, S., (1995) Progesterone-mediated efflux of cytosolic 
chloride during human sperm acrosome reaction. Biochem. Biophys. Res. Commun. 
213:774-780. 
 
13. Waldegger, S., Beisse, F., Apfel, H., Breit, S., Kolb, H.A., Haussinger, D., and 
Lang, F., (1995) Electrophysical effects of progesterone on hepatocytes. Biochim. 
Biophys. Acta 1266:186-190. 
 
14. Wasserman, W.J., Pinto, L.H., O’Conner, C.M., and Smith, L.D., (1980) 
Progesterone induces a rapid increase in [Ca
2+
]in of Xenopus laevis oocytes. Proc. 
Natl. Acad. Sci. USA. 77:1534-1536. 
 
15. Lan, N.C., Bolger, M.B., and Gee, K.W., (1991) Identification and 
characterization of a pregnane steroid recognition site that is functionally coupled to 
an expressed GABAA receptor. Neurochem. Res. 16:347-356. 
 
16. Grazzini, E., Guillon, G., Mouillac, B., and Zingg, H.H., (1998) Inhibition of 
oxytocin receptor function by direct binding of progesterone. Nature. 392:509-512. 
 
17. Wehling, M., (1995) Looking beyond the dogma of genomic steroid action: 
insights and facts of the 1990s. J. Mol. Med. 73:439-447. 
 
18. Falkenstein, E., Meyer, C., Eisen, C., Scriba, P.C., and Wehling, M., (1996) 
Full-lentgh cDNA sequence of a progesterone membrane-binding protein from 
porcine vascular smooth muscle cells. Biochem. Biophys. Res. Commum. 229:86-
89. 
 
19. Gerdes, D., Wehling, M., Leube, B., and Falkenstein, E., (1998) Cloning and 
tissue expression of two putative steroid membrane receptors. Biol Chem. 379:907-
911. 
 
20. Nolte, I., Jeckel, D., Wieland, F.T., and Sohn, K., (2000) Localization and 
topology of ratp28, a member of a novel family of putative steroid-binding proteins. 
Biochem. Biophys. Acta 1543:123-130. 
 
21. Kwon, S., Lunn, R.M., O’Brien, D.A., Bell, D.A., and Eddy, E.M., (1998) Biol. 
Reprod. Supplement 1, p. 78. 
 
22. Gray, P.N., (2001) Characterization of the membrane associated progesterone 
receptor (MAPR) homologues in Saccharomyces cerevisiae and Arabidopsis 
Thaliana. Thesis, Georgia Institute of Technology. 
 
23. Mifsud, W., and Bateman, A., (2002) Membrane-bound progesterone receptors 
contain a cytochrome b5-like ligand-binding domain. Genome Biology 3(12):1-5. 
 
 128 
24. Falkenstein, E., Heck, M., Gerdes, D., Grube, D., Christ, M., Weigel, M., 
Buddhikot, M., Meizel, S., and Wehling, M., (1999) Specific progesterone 
binding to a membrane protein and related nongenomic effects on Ca
2+
 fluxes in 
sperm. Endocrinology 140:5999-6002. 
 
25. Meyer, C., Schmid, R., Scriba, P.C., and Wehling, M., (1996) Purification and 
partial sequencing of high-affinity progesterone-binding site(s) from porcine liver 
membranes. Eur. J. Biochem. 239:726-731. 
 
26. Buddhikot, M., Falkenstein, E., Wehling, M., and Meizel, S., (1999) Recognition 
of a human sperm surface protein involved in the progesterone-initiated acrosome 
reaction by antisera against an endomembrane progesterone binding protein from 
porcine liver. Mol. Cell Endocrinol. 158:187-193. 
 
27. Falkenstein, E., Schmibding, K., Lange, A., Meyer, C., Gerdes, D., Welsch, U., 
and Wehling, M., (1998) Localization of a putative progesterone membrane 
binding protein in porcine hepatocytes. Cell. Mol. Biol. 44:571-578. 
 
28. Krebs, C.J., Jarvis, E.D., Chan. J., Lydon. J.P., Ogawa, S., and Pfaff. D.W., 
(2000) A membrane-associated progesterone-binding protein, 25-Dx, is regulated 
by progesterone in brain regions involved in femaile reproductive behaviors. Proc. 
Nat. Acad. Sci. USA 97:12816-12821. 
 
29. Runko, E., Wideman, C., and Kaprielian, Z., (1999) Cloning and Expression of 
VEMA: A Novel Ventral Midline Antigen in the Rat CNS. Mol. Cell. Neuro. 
14:428-443. 
 
30. Raza, F.S., Takemori, H., Tojo, H., Okamoto, M., Vinson, G.P., (2001) 
Identification of the rat adrenal zona fsciculata/reticularis specific protein, inner 
zone antigen (IZAg), as the putative membrane progesterone receptor. Eur. J. 
Biochem. 268:2141-2147. 
 
31. Radisky, E., and Poulter, C.D., (2000) Squalene synthase: steady-state, pre-state, 
and isotope-trapping studies. Biochem. 39: 1748-1760. 
 
32. Gemmerich, A.R., (1981) Ultrastructure and enzymatic studies on the development 
of microbodies in germinating spores of the fern Anemia phyllitidis.  Z. 
Pflanzenphysiol. 226:497-509. 
 
33. Jayaram, A., Bal, A.K., (1991) Oleosomes (lipid bodies) in nitrogen-fixing peanut 
nodules.  Plant Cell Environ. 14:195-203. 
 
34. Christiansen, K., and Jensen, P.K., (1972) Membrane bound lipid particles from 




35. Clausen, M.K., Christiansen, K., Jensen, P.K., and Behnke, O., (1974) Isolation 
of lipid particles from baker’s yeast (Saccharomyces cerevisiae). FEBS Lett. 
43:176-179. 
 
36. Athenstaedt, K., Zweytick, D., Jandrositz, A., Kohlwein, S.D., and Daum, G., 
(1999) Identification and characterization of major lipid particle proteins of the 
yeast Saccharomyces cerevisiae. J. Bacteriol. 181:6441-6448. 
 
37. Schatz, G., (1979) How mitochondria import proteins from the cytoplasm.  FEBS 
Lett. 103:203-211. 
 
38. Neupert, W., and Schatz, G., (1981) How proteins are transported into 
mitochondria.  Trends Biochem. Sci. 6:1-4. 
 
39. Gasser, S.M., Daum, G., and Schatz, G., (1982) J. Biol. Chem. 257:13034-13041. 
 
40. Scheiter, R., (1999) Electrospray ionization tandem mass spectrometry (E.S.I.-
M.S./M.S.) analysis of the lipid molecular species composition of yeast subcellular 
membranes reveals acyl chain-based sorting/remodeling of distinct molecular 
species en route to the plasma membrane. J. Cell Biol. 146:741-754. 
 
41. Lees, N.D., Bard, M., and Kirsch, D.R., (1999) Biochemistry and molecular 
biology of sterol synthesis in Saccharomyces cerevisiae. Crit. Rev. Biochem. Mol. 
Biol. 34:33-47. 
 
42. Nes, W.D., Xu, S.H., and Haddon, W.F. (1989) Evidence for similarities and 
differences in the biosynthesis of fungal sterols.  Steroids 53:533-558. 
 
43. Arthington, B.A., Bennett, L.G., Skatrud, P.L., Guyun, C.J., Barbuch, R.J., 
Ulbright, C.E., and Bard, M., (1991) Cloning, disruption and sequence of the 
gene encoding yeast C-5 sterol desaturase. Gene 102:39-44. 
 
44. Barton, D.H.R., Ganatilaka, A.A.L., Jarman, T.R., Widdowson, D.A., Bard, 
M., and Woods, R.A., (1975) Biosynthesis of terpenes and steroids.  Part X.  The 
sterols of some yeast mutants doubly defective in ergosterol biosynthesis.  J. Chem. 
Soc, Perkin 1, 88-92. 
 
45. Ashman, W.H., Barbuch, R.J., Ulbright, C.E., Jarret, H.W., and Bard, M., 
(1991) Cloning and disruption of the yeast C-8 sterol isomerase gene. Lipids 
26:628-632. 
 
46. Lorentz, R.T., and Parks L.W., (1991) Physiological effects of fenpropimorph on 
wild-type Saccharomyces cerevisiae and fenpropimorph-resistant mutants. 
Antimicrob. Agents Chemother 35:1532-1537. 
 
 130 
47. Campagnoni, C., Holmlumd, C.E., and Whittaker, N., (1977) The effect of 
triparanol on the composition of free and esterified sterols of Saccharomyces 
cerevisiae. Arch. Biochem. Biophys. 184:555-560. 
 
48. Rodriguez, R.J., and Parks, L.W., (1983) Structural and physiological features of 
sterols necessary to satisfy bulk membrane and sparking requirements in yeast 
sterol auxotrophs. Arch. Biochem. Biophys. 225:861-871. 
 
49. Munn, A.L., HeesePeck, A., Stevenson, B.J., Pichler, H., and Riezman, H., 
(1999) Specific sterols required for the internalization step of endocytosis in yeast. 
Mol. Biol. Cell 10:3943-3957. 
 
50. Rietveld, A., and Simons, K., (1998) The different miscibility of lipids as the basis 
for the formation of functional membrane rafts. Biochem. Biophys. Res. Commun. 
1376:467-479. 
 
51. Bagnat, M., Keranen, S., Shevchenko, A., and Simons, K., (2000) Lipid rafts 
function in biosynthetic delivery of proteins to the cell surface in yeast. Proc. Natl. 
Acad. Sci. USA 97:3254-3259. 
 
52. Reinhart, M.P., (1990) Intracellular sterol trafficking. Experientia 46:599-611. 
 
53. Colbeer, T., and Threfall, D.R., (1989) Biosynthesis of terpenoid lipids, p. 116, In 
C. Ratledge and S.G. Wilkinson (ed.) Microbial lipids, Academic Press, Inc., New 
York. 
54. Taylor, F.R., and Parks, L.W., (1978) Metabolic interconversion of free sterols 
and steryl esters in Saccharomyces cerevisiae. J. Bacteriol. 136:531-537. 
 
55. Zweytick, D., Hrastnik, C., Kohlwein, S.D., and Daum, G., (2000) Biochemical 
characterization and subcellular localization of the sterol C-24(28) reductase, 
Erg4p, from the yeast Saccharomyces cerevisiae. FEBS Lett. 470:83-87. 
 
56. Paultauf, F., Kohlwein, S.D., and Henry, S.A., (1992) The Molecular and 
Cellular Biology of the Yeast Saccharomyces cerevisiae:  Gene Expression, pp. 
415-500, Cold Spring Harbor Laboratory Press, Cold Spring Harbor. 
 
57. Leber, R., Zinser, E., Zellnig, G., Paltauf, F., and Daum, G., (1994) 
Characterization of the lipid particles of the yeast, Saccharomyces cerevisiae. Yeast 
10:1421-1428. 
 
58. Lewis, T.A., Rodriguez, R.J., and Parks, L.W., (1987) Relationship between 
intracellular sterol content and sterol esterification and hydrolysis in Saccharomyces 
cerevisiae. Biochim. Biophys. Acta 921:205-212. 
 
 131 
59. Billheimer, J.T., and Reinhart, M.P., (1990) In Subcellular Biochemistry-
Intracellular Transfer of Lipid Molecules (Hilderson, H.J., ed.), pp. 301-331, 
Plenum Press, New York. 
 
60. Reinhart, M.P., (1990) Intracellular sterol trafficking. Experientia 46:599-611. 
 
61. Leber, R., Zinser, E., Hrastnik, C., Paltauf, F., and Daum, G., (1995) Export of 
steryl esters from lipid particles and release of free sterols in the yeast, 
Saccharomyces cerevisiae. Biochim. Biophys. Acta 1234:119-126. 
 
62. Bailey, R.B., and Parks, L.W., (1975) Yeast sterol esters and their relationship to 
the growth of yeast. J. Bacteriol. 124:606-612. 
 
63. Zweytick, D., Leitner, E., Kohlwein, S.D., Yu, C., Rothblatt, J., and Daum, G., 
(2000) Contribution of Are1p and Are2p to steryl ester synthesis in the yeast 
Saccharomyces cerevisiae. Eur. J. Biochem. 267:1075-1082. 
 
64. Daum, G., (1985) Lipids of mitochondria. Biochem. Biophys. Acta 822:1-42. 
 
65. Tuller, G., and Daum, G., (1995) Import of sterols into mitochondria of the yeast 
Saccharomyces cerevisiae. FEBS Lett. 372:29-32. 
 
66. Hand, R.A., Jia, N., Bard, M., and Craven, R.J., (2003) Saccharomyces 
cerevisiae Dap1p, a novel DNA damage response protein related to the mammalian 
membrane-associated progesterone receptor. Eukary. Cell 2:306-317. 
 
67. Ke, F.C., and Ramirez, V.D., (1990) Binding of progesterone to nerve cell 
membranes of rat brain using progesterone conjugated to 125I-bovine serum 
albumin as a ligand. Biol. Reprod. 49:980-988. 
68. Ozaki, T., Nakamura, Y., Enomoto, H., Hirose, M., and Sakiyama, S., (1995) 
Cancer Res. 55:895-900. 
 
69. Yeast protein-GFP localization study at UCSF. 
http://yeastgfp.ucsf.edu/getOrf.php?orf=YPL170W 
 
70. Leber, R., Landl, K., Zinser, E., Ahorn, H., Spök, A., Kohlwein, S.D., 
Turnowsky, F., and Daum, G., (1998) Dual localization of squalene epoxidase, 
Erg1p, in yeast reflects a relationship between the endoplasmic reticulum and lipid 
particles.  Mol. Biol. Cell 9: 375-386. 
 
71. Milla, P., Athenstaedt, K., Viola, F., Oliaro-Bosso, S., Kohlwein, S.D., Daum, 
G., and Balliano, G., (2002) Yeast oxidosqualene cyclase (Erg7p) is a major 
component of lipid particles.  J. Biol. Chem. 277:2406-2412. 
 
72. Leber, R., Zenz, R., Shröttner, K., Fuchsbichler, S., Pühringer, B., and 
Turnowsky, F., (2001) A novel sequence element is involved in the transcriptional 
 132 
regulation of expression of the ERG1 (squalene epoxidase) gene in Saccharomyces 
cerevisiae. Eur. J. Biochem. 268: 914-924. 
 
73. Daum, G., Lees, N.D., Bard, M., and Dickson, R., (1998) Biochemistry, Cell 
Biology and Molecular Biology of Lipids of Saccharomyces cerevisiae. Yeast 14: 
1471-1510. 
 
74. Smith, S.J., and Parks. L.W.,  (1993) The ERG3 gene in Saccharomyces 
cerevisiae is required for the utilization of respiratory substrates and in heme-
deficient cells. Yeast 9:1177-1187. 
 
75. Smith, S.J., and Parks. L.W.,  (1997) Requirements of heme to replace the 
sparking sterol function in the yeast Saccharomyces cerevisiae. Biochim. Biophys. 
Acta 1345:71-76. 
 
76. Dahl, C., Biemann, H.P., and Dahl, J., (1987) A protein kinase antigenically 
related to pp60 src possibly involved in yeast cell cycle control: positive in vivo 
regulation of sterol. Proc. Natl. Acad. Sci. USA 84:4012-4016. 
 
77. Lorenz, R.T., Rodriguez, R.J., Lewis, T.A., and Parks, L.W., (1986) 
Characteristics of sterol uptake in Saccharomyces cerevisiae. J. Bacteriol. 167: 981-
985. 
 
78. Yeast protein-GFP localization study at UCSF.  
http://yeastgfp.ucsf.edu/getOrf.php?orf=YHR007C 
 
79. Yeast GRID resource 
http://biodata.mshri.on.ca/yeast_grid/servlet/SearchResults?keywords=YHR007C 
 
80. Kontoyiannis, D.P., (2000) Modulation of fluconazole sensitivity by the interaction 
of mitochondria and Erg3p in Saccharomyces cerevisiae. J. Antimicro. Chemo. 46: 
191-197. 
 
81. Mo, C., Milla, P., Athenstaedt, K., Ott, R., Balliano, G., Daum, G., and Bard, 
M., (2003) In yeast sterol biosynthesis the 3-keto reductase  protein (Erg27p) is 
required for oxidosualene cyclase (Erg7p) activity. Biochim. Biophys. Acta 1633: 
68-74. 
82. Mo, C., Valachovic, M., Bard, M., (2004) The ERG28-encoded protein, Erg28p, 
interacts with both the sterol C-4 demethylation enzyme complex as well as the late 
biosynthetic protein, the C-24 sterol methyltransferase (Erg6p). Biochim. Biophys. 
Acta Atricle in Press. 
 
83. Bard, M., Bruner, D.A., Pierson, C.A., Lees, N.D., Biermann, B., Frye, L., 
Koegel, C., and Barbuch, R., (1996) Cloning and chatacterization of ERG25, the 
Saccharomyces cerevisiae gene encoding C-4 sterol methyl oxidase. Proc. Natl. 
Acad. Sci. USA 93: 186-190. 
 133 
 
84. Bard, M., Downing, J.F., (1981) Genetic and biochemical aspects of yeast sterol 
regulation involving 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Gen. 
Microbiol. 125: 415-20. 
 
85. Bitter, G.A., and Egan, K.M., (1984) Expression of heterologous genes in 
Saccharomyces cerevisiae from vectors utilizing the glyceraldehydes-3-phosphate 
dehydrogenase gene promoter. Gene 32: 263-274. 
 
86. Bumann, M., Djafarzadeh, S., Oberholzer, A.E., Bigler, P., Altmann, M., 
Trachsel, H., Baumann, U., (2004) Crystal Structure of Yeast Ypr118w, a 
Methylthioribose-1-phosphate Isomerase Related to Regulatory eIF2B Subunits. J. 
Biol. Chem. 279: 37087-37094. 
 
87. Yeast GRID resource 
http://biodata.mshri.on.ca/yeast_grid/servlet/SearchResults?keywords=DAP1 
 
88. Bourne, H.R., Sanders, D.A., and McCormick, F., (1991) The GTPase 
superfamily: conserved structure and molecular mechanism. Nature 349: 117-127. 
 
89. Caldon, C.E., Yoong, P., and March, P.E., (2001) Evolution of a molecular 
switch: universal bacterial GTPase regulate ribosome function. Mol. Micro. 41: 
289-297. 
 
90. Bourne, H.R., (1995) GTPase: a family of molecular switches and clocks. Phil. 
Trans. R. Soc. London 349: 283-289. 
 
91. Yeast GRID resource 
http://biodata.mshri.on.ca/yeast_grid/servlet/SearchResults?keywords=ypr118w 
 
92. Arselin, G., Vaillier, J., Graves, P., and Velours, J., (1996) ATP Synthase of 
Yeast Mitochondria. J. Biol. Chem. 271: 20284-20290. 
 
93. Senior, A.E., (1988) Physiol. Rev. 68: 177-231. 
 
94. Yeast GRID resource 
http://biodata.mshri.on.ca/yeast_grid/servlet/SearchResults?keywords=DAP1 
 
95. Feaver, W.J., Henry. N.L., Wang, Z., Wu, X., Svejstrup, J.Q., Bushnell, D.A., 
Friedberg, E.,C., and Kornberg, R.D., (1997) Genes for Tfb2, Tfb3, and Tfb4 
Subunits of Yeast Transcription/Repair Factor IIH. J. Biol. Chem. 272: 19319-
19327. 




97. Brown, M.S., and Goldstein, J.L., (1999) A proteolytic pathway that controls the 
cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA 96: 
11041-11048. 
 
98. Goldstein, J.L., and Brown, M.S., (1990) Regulation of the mevalonate pathway. 
Nature 343: 425-430. 
 
99. Yeast GRID resource 
http://biodata.mshri.on.ca/yeast_grid/servlet/SearchResults?keywords=DAP1 
 
100. Gong, X., and Chang, A., (2001) A mutant plasma membrane ATPase, Pma1-10, 
is defective in stability at the yeast cell surface. Proc. Natl. Acad. Sci. USA 98: 
9104-9109. 
 
101. Bligh, E.G., and Dyer, W.J., (1959) A rapid method of total lipid extraction and 
purification. Can. J. Physiol. 37: 911-917. 
 
102. Folch, J, Lees, M., Sloane, Stanley G.H., (1957) A simple method for the isolation 
and purification of total lipides from animal tissues.  J. Biol. Chem. 226: 497-509. 
 
103. Hand, R.A., and Craven, R.J., (2003) Hpr6.6 mediates cell death in oxidative 
damage in MCF-7 human breast cancer cells.  J. Cell. Biochem. 90: 534-547. 
 
104. Ruan, B., Lai, P.S., Yeh, C.W., Wilson, W.K., Pang, J., Xu, R., Matsuda, 
S.P.T., and Schroepfer, G.J., (2002) Alternative pathways of sterol synthesis in 
yeast: Use of C27 sterol tracers to study aberrant double-bond migrations and 
evaluate their relative importance. Steroids 67: 1109-1119. 
 
105. Nes, W.D., McCourt, B.S., Marshall, J.A., Ma, J., Dennis, A.L., Lopez, M., Li, 
H., and He, L., (1999) Site-directed mutagenesis of the sterol methyl transferase 
active site from Saccharomyces cerevisiae: results in formation of novel 24-ethyl 
sterols. J. Org. Chem. 64: 1535-1542. 
 
106. Min, L., Takemori, H., Nonaka, Y., Katoh, Y., Doi, J., Horike, N., Osamu, H., 
Raza, F.S., Vinson, G.P., and Okamoto M., (2004) Characterization of the 
adrenal-specific antigen IZA (inner zone antigen) and its role in the steroidogenesis. 
Mol. Cell. Endocrin. 215: 143-148. 
 
107. ACD/NIST MS Database.  
http://www.acdlabs.com/products/spec_lab/exp_spectra/spec_libraries/nist_ms.html 
 
108. Palisade complete MS Library 600K. http://www.palisade-ms.com/complete.htm 
 
109. Gerst, N., Ruan, B., Pang, J., Wilson, W.K., and Schroepfer, Jr., G.J., (1997) 
An updated look at the analysis of unsaturated C27 sterols by gas chromatography 
and mass spectrometry. J. Lipid Res. 38: 1685-1701. 
 135 
110. Sakamoto, H., Ukena, K., Takemori, H., Okamoto, M., Kawata, M., and 
Tsutsui, K., (2004) Expression and localization of 25-Dx, a membrane-associated 
putative progesterone-binding protein, in the developing Purkinje cell.  
Neuroscience 126: 325-334. 
 
111. Ho, Y., Gruhler, A., Heilbut, A., Bader, G.D., Moore, L., Adams, S.L., Millar, 
A., Taylor, P., Bennett, K., Boutilier, K., Yang, L., Wolting, C., Donaldson, I., 
Schandorff, S., Shewnarane, J., Vo, M., Taggart, J., Goudreault, M., Muskat, 
B., Alfarano, C., Dewar, D., Lin, Z., Michalickova, K., Willems, A.R., Sassi, H., 
Nielsen, P.A., Rasmussen, K.J., Andersen, J.R., Johansen, L.E., Hansen, L.H., 
Jespersen, H., Podtelejnikov, A., Nielsen, E., Crawford, J., Poulsen, V., 
Sorensen, B.D., Matthiesen, J., Hendrickson, R.C., Gleeson, F., Pawson, T., 
Moran, M.F., Durocher, D., Mann, M., Hogue, CW., Figeys, D., and Tyers, M., 
(2002) Systematic identification of protein complexes in Saccharomyces cerevisiae 
by mass spectrometry. Nature 415:180-183. 
 
112. Parsons, A.B,, Brost, R.L., Ding, H., Li, Z., Zhang, C., Sheikh, B., Brown, 
G.W., Kane, P.M., Hughes, T.R., Boone, C., (2004) Integration of chemical-
genetic and genetic interaction data links bioactive compounds to cellular target 
pathways. Nat. Biotechnol. 22:62-69. 
 
113. Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M., and Sakaki, Y., (2001) 
A comprehensive two-hybrid analysis to explore the yeast protein interactome.  
Proc. Natl. Acad. Sci. U S A 98:4569-4574. 
 
114. Gasch, A.P., Spellman, P.T., Kao, C.M., Carmel-Harel, O., Eisen, M.B., Storz, 
G., Botstein, D., Brown, P.O., (2000) Genomic expression programs in the 
response of Yeast cells to environmental changes. Mol. Biol. Cell 11:4241-4257. 
 
115. Gaber, R.F., Copple, D.M., Kennedy, B.K., Vidal, M., Bard, M., (1989) The 
yeast gene ERG6 is required for normal membrane function but is not essential for 
biosynthesis of the cell-cycle-sparking sterol.  Mol. Cell. Biol. 9:3447-3456. 
